1
|
Burel J, Boulouis G, Zhu F, Kerleroux B, Shotar E. From 2018 to 2023: A five-year journey of trainee-led network research by the Jeunes en Neuroradiologie Interventionnelle (JENI)-Research Collaborative. J Neuroradiol 2024; 51:101191. [PMID: 38556368 DOI: 10.1016/j.neurad.2024.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2024] [Accepted: 03/28/2024] [Indexed: 04/02/2024]
Affiliation(s)
- Julien Burel
- Department of Radiology, Rouen University Hospital, Rouen, Normandy, France.
| | - Grégoire Boulouis
- Department of Diagnostic and Interventional Neuroradiology, University Hospital of Tours, Tours, Centre, France
| | - François Zhu
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France
| | - Basile Kerleroux
- Department of Neuroradiology, APHM La Timone, Marseille, France; Department of Radiology, Centre Hospitalier de Bastia, Bastia, France
| | - Eimad Shotar
- Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France
| |
Collapse
|
2
|
Zhu F, Kerleroux B, Pruvo JP, Naggara O, Caroff J, Berge J, Alamowitch S, Desal H, Boulouis G. Breaking the glass ceiling for Mechanical Thrombectomy access in France. J Neuroradiol 2024; 51:43-46. [PMID: 38135248 DOI: 10.1016/j.neurad.2023.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Accepted: 12/16/2023] [Indexed: 12/24/2023]
Affiliation(s)
- François Zhu
- Imagerie Adaptative Diagnostique et Interventionnelle (IADI), University of Lorraine; INSERM U1254; Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France
| | - Basile Kerleroux
- Department of Neuroradiology, CHU Timone, 264 Rue Saint-Pierre, Marseille, France
| | - Jean Pierre Pruvo
- Neuroradiology Department. Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Univ. Lille, Lille, France
| | - Olivier Naggara
- Neuroradiology Department, GHU Paris Psychiatrie et Neurosciences; INSERM U1266; Université Paris-Cité, Paris, France; Pediatric Radiology Department, APHP Necker-Enfants Malades University Hospital, Université Paris-Cité, Paris, France
| | - Jildaz Caroff
- NEURI the Brain Vascular Center, Bicetre Hospital Interventional Neuroradiology, Le Kremlin-Bicetre, Île-de-France, France
| | - Jérôme Berge
- Neuroradiology department, University Hospital, Bordeaux, France
| | - Sonia Alamowitch
- Urgences Cérébro-Vasculaires, Hôpital Pitié-Salpêtrière, AP-HP, Hôpital Saint-Antoine, Sorbonne Université, Paris, France; STARE Team, iCRIN, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France
| | - Hubert Desal
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France
| | - Grégoire Boulouis
- Diagnostic and Interventional Neuroradiology, CIC-IT 1415, CHRU de Tours, INSERM 1253 iBrain, Tours, Centre Val de Loire, France.
| |
Collapse
|
3
|
Ouyang H, Jiang H, Huang J, Liu Z. COVID-19 Pandemic Brings Challenges to the Management of Stroke-The Differences Between Stroke Cases Admitted to a Tertiary Hospital Before and During COVID-19 Pandemic in China. Risk Manag Healthc Policy 2023; 16:2893-2905. [PMID: 38155847 PMCID: PMC10752818 DOI: 10.2147/rmhp.s435094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Accepted: 12/11/2023] [Indexed: 12/30/2023] Open
Abstract
Background An international public health emergency has resulted from the emergence of the new coronavirus-2. Both direct and indirect influences have been felt on the treatment of acute stroke. However, no conclusive link between COVID-19 and the alleged decline in admissions for stroke-related reasons has been established, and the findings of recent studies are contentious. Most of those researches are not made use of authentic data. Therefore, the goal of this study is to examine how the COVID-19 pandemic has affected hospital admissions for stroke patients, to provide a basis for managing stroke patients in hospitals during COVID-19 pandemic. Methods This retrospective study took place at the People's Hospital of Peking University in Beijing, China. For each patient, interventions such as the application of tissue plasminogen activator (tPA) were examined. We recorded each patient's outcomes. The stroke patients' hospital admissions were compared to the average of the prior year. As the time span of interest, we selected the epidemic period (January 2020 to December 2020). Results When compared to the previous year in the pre-COVID period, mean monthly stroke hospitalizations decreased during the pandemic by 54.42% (P<0.001); average lengths of stay (ALOS) increased; and non-emergency admissions decreased by 78.8% (P<0.001). The monthly volume of stroke patients exceeding the intravenous thrombolysis (IVT) window decreased by 25% and 59.73%, respectively (P <0.001). There was a 5.3% increase in the percentage of IVT or within IVT time window in male stroke patients (p=0.019; p=0.049). During COVID-19, the proportion of non-local patients among male stroke patients decreased by 10% compared with the previous year (p=0.006). Conclusion The COVID-19 epidemic has had a negative impact on stroke management in China, healthcare systems must work to assess and adapt to the new reality.
Collapse
Affiliation(s)
- Hui Ouyang
- Department of Neuromedicine, Peking University People’s Hospital, Beijing, People’s Republic of China
| | - Hong Jiang
- Department of Neuromedicine, Peking University People’s Hospital, Beijing, People’s Republic of China
| | - Jin Huang
- Department of Emergency, Yiyang Central Hospital, Yiyang, Hunan, People’s Republic of China
| | - Zunjing Liu
- Department of Neuromedicine, Peking University People’s Hospital, Beijing, People’s Republic of China
| |
Collapse
|
4
|
Brosnan C, Brennan D, Reid C, Power S, O'Hare A, Brennan P, Thornton J, Crockett M. The impact of the COVID-19 pandemic on the provision of endovascular thrombectomy for stroke: an Irish perspective. Ir J Med Sci 2023; 192:3073-3079. [PMID: 36792763 PMCID: PMC9931560 DOI: 10.1007/s11845-023-03314-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Accepted: 02/08/2023] [Indexed: 02/17/2023]
Abstract
BACKGROUND The COVID-19 pandemic produced unprecedented challenges to healthcare systems. These challenges were amplified in the setting of endovascular thrombectomy (EVT) for large vessel occlusion strokes given the time-sensitive nature of the procedure. AIMS To assess the impact of the COVID-19 pandemic on service provision at the primary endovascular stroke centre in Ireland. METHODS A retrospective review of the National Thrombectomy Service database was performed. All patients undergoing EVT from 1 January to 31 December inclusive of 2019 to 2021 were included. Patient demographics, functional outcomes and endovascular treatment time metrics were recorded. RESULTS Data from 2019, 2020 and 2021 were extracted. Three hundred seven thrombectomies were performed in 2019 and 2020; this number increased to 327 in 2021. Median time from arrival to groin puncture for thrombectomy was 64 min in 2019, increasing to 65 min in 2020. In 2021, this decreased to 52 min. Median time taken from groin puncture to first perfusion remained stable from 2019 to 2021 years at 20 min. Total duration of emergency thrombectomies reduced from 32 min in 2019 to 27 min in 2020. This increased to 29 min in 2021. CONCLUSIONS Despite the myriad of challenges presented by the pandemic, service provision at the primary Irish ESC, and the referring hospitals, has proven to be robust. Procedural time metrics were maintained whilst the expected reduction in number of EVTs performed did not materialise, there actually being a significant increase in number of EVTs performed in the pandemic's second year.
Collapse
Affiliation(s)
- Conor Brosnan
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland.
- Faculty of Radiologists, RCSI, Dublin, Ireland.
| | - David Brennan
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
| | - Conor Reid
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
| | - Sarah Power
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
- National Thrombectomy Service, Beaumont Hospital, Dublin, Ireland
| | - Alan O'Hare
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
- National Thrombectomy Service, Beaumont Hospital, Dublin, Ireland
| | - Paul Brennan
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
- National Thrombectomy Service, Beaumont Hospital, Dublin, Ireland
| | - John Thornton
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
- National Thrombectomy Service, Beaumont Hospital, Dublin, Ireland
| | - Matthew Crockett
- Department of Neuroradiology, Beaumont Hospital, Beaumont, Dublin 9, D09 V2N0, Ireland
- Faculty of Radiologists, RCSI, Dublin, Ireland
- National Thrombectomy Service, Beaumont Hospital, Dublin, Ireland
| |
Collapse
|
5
|
Khan Y, Verhaeghe N, Devleesschauwer B, Cavillot L, Gadeyne S, Pauwels N, Van den Borre L, De Smedt D. The impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review. EUROPEAN HEART JOURNAL. QUALITY OF CARE & CLINICAL OUTCOMES 2023; 9:647-661. [PMID: 37667483 DOI: 10.1093/ehjqcco/qcad051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 08/17/2023] [Accepted: 08/30/2023] [Indexed: 09/06/2023]
Abstract
AIMS Cardiovascular diseases (CVD) are the leading cause of death worldwide. The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare systems, causing delays in essential medical services, and potentially impacting CVD treatment. This study aims to estimate the impact of the pandemic on delayed CVD care in Europe by providing a systematic overview of the available evidence. METHODS AND RESULTS PubMed, Embase, and Web of Science were searched until mid-September 2022 for studies focused on the impact of delayed CVD care due to the pandemic in Europe among adult patients. Outcomes were changes in hospital admissions, mortality rates, delays in seeking medical help after symptom onset, delays in treatment initiation, and change in the number of treatment procedures. We included 132 studies, of which all were observational retrospective. Results were presented in five disease groups: ischaemic heart diseases (IHD), cerebrovascular accidents (CVA), cardiac arrests (CA), heart failures (HF), and others, including broader CVD groups. There were significant decreases in hospital admissions for IHD, CVA, HF and urgent and elective cardiac procedures, and significant increases for CA. Mortality rates were higher for IHD and CVA. CONCLUSION The pandemic led to reduced acute CVD hospital admissions and increased mortality rates. Delays in seeking medical help were observed, while urgent and elective cardiac procedures decreased. Adequate resource allocation, clear guidelines on how to handle care during health crises, reduced delays, and healthy lifestyle promotion should be implemented. The long-term impact of pandemics on delayed CVD care, and the health-economic impact of COVID-19 should be further evaluated.
Collapse
Affiliation(s)
- Yasmine Khan
- Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium
- Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium
- Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium
| | - Nick Verhaeghe
- Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium
- Research Institute for Work and Society, KU Leuven, Leuven 3000, Belgium
- Department of Rehabilitation Sciences, Ghent University, Ghent 9000, Belgium
| | - Brecht Devleesschauwer
- Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium
- Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke 9000, Belgium
| | - Lisa Cavillot
- Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium
- Research Institute of Health and Society, University of Louvain, Brussels 1200, Belgium
| | - Sylvie Gadeyne
- Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium
| | - Nele Pauwels
- Faculty of Medicine, Ghent University, Ghent 9000, Belgium
| | - Laura Van den Borre
- Department of Epidemiology and Public Health, Sciensano, Brussels 1050, Belgium
- Department of Sociology, Interface Demography, Vrije Universiteit Brussel, Brussels 1050, Belgium
| | - Delphine De Smedt
- Department of Public Health and Primary Care, Ghent University, Ghent 9000, Belgium
| |
Collapse
|
6
|
Malka D, Janot K, Pasi M, Desilles JP, Marnat G, Sibon I, Consoli A, Dargazanli C, Arquizan C, Gory B, Richard S, Naggara O, Clarençon F, Rosso C, Bourcier R, Eker O, Caroff J, Lapergue B, Boulouis G. Effects of weather conditions on endovascular treatment case volume for patients with ischemic stroke. J Neuroradiol 2023; 50:593-599. [PMID: 37442271 DOI: 10.1016/j.neurad.2023.07.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Revised: 07/01/2023] [Accepted: 07/01/2023] [Indexed: 07/15/2023]
Abstract
BACKGROUND Weather conditions have been shown to influence the occurrence of cardiovascular events. We tested the hypothesis that weather parameters may be associated with variations of case volume of endovascular treatment (EVT) for acute ischemic stroke. METHODS Individual data from the ETIS (Endovascular Treatment in Ischemic Stroke) French national registry were matched to local weather stations. Meteorological parameters (rainfall, humidity, atmospheric pressure, air temperature) were gathered from national online resources. Weather readings and EVT case volumes were annually standardized per weather station and EVT center, and their associations tested with non-parametric univariable and generalized linear statistical models. RESULTS Between 2015 and 2021, 9913 EVT procedures addressed by 135 primary stroke units were matched to weather conditions. The mean daily case volume per center was 0.41 [StDev 0.33], and there was a median of 0.84 procedures daily linked to a weather station [StDev 0.47]. We found lower atmospheric pressure (β estimate -0.04; 95%CI[-0.07;-0.03], p<0.001), higher humidity (β estimate 0.07; 95%CI [0.05;0.09], p<0.001) and lower temperatures (β estimate -0.08; 95%CI[-0.10;-0.06], p<0.001) to be associated with higher standardized EVT daily case volumes. These associations were stable when testing them across strata of binned EVT standardized case volumes. CONCLUSIONS Our study suggests that lower ambient temperature, lower atmospheric pressure, and higher air humidity are associated with significantly more daily EVT cases in a European temperate country. These results may provide insight into both system of care optimization at times of climate change and intracranial LVO pathophysiology. REGISTRATION-URL: https://clinicaltrials.gov/ct2/show/NCT03776877.
Collapse
Affiliation(s)
- David Malka
- Diagnostic and Interventional Neuroradiology Department, Tours University Hospital, INSERM UMR 1253 iBrain, 2 Bd Tonnellé, Centre Val de Loire, Tours, France
| | - Kevin Janot
- Diagnostic and Interventional Neuroradiology Department, Tours University Hospital, INSERM UMR 1253 iBrain, 2 Bd Tonnellé, Centre Val de Loire, Tours, France
| | - Marco Pasi
- Stroke Unit, Tours University Hospital, INSERM UMR 1253 iBrain, Tours, Centre Val de Loire, France
| | - Jean-Philippe Desilles
- Interventional Neuroradiology Department, Biological Resource Center, Hôpital Fondation Adolphe de Rothschild, Paris, France
| | - Gaultier Marnat
- Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France
| | - Igor Sibon
- Neuroradiology Department, Bordeaux University Hospital, Bordeaux, France
| | - Arturo Consoli
- Department of Neuroradiology and Stroke Unit, Foch Hospital, Suresnes, France, University of Versailles Saint-Quentin-des-Yvelines, France
| | - Cyril Dargazanli
- Department of Neuroradiology, Gui de Chauliac Hospital, Montpellier University Hospital Center, Montpellier, France
| | - Caroline Arquizan
- Stroke Unit, Gui de Chauliac Hospital, Montpellier University Hospital Center, Montpellier, France
| | - Benjamin Gory
- Department of Diagnostic and Therapeutic Neuroradiology, CHRU-Nancy, Nancy F-54000, France; IADI, INSERM U1254, Université de Lorraine (B.G.), Nancy F-54000, France
| | - Sébastien Richard
- CHRU-Nancy, Department of Neurology, Stroke Unit, Nancy F-54000, France; CHRU-Nancy, CIC-P 1433 (S.R.), INSERM U1116, Nancy F-54000, France
| | - Olivier Naggara
- Department of Neuroradiology, INSERM 1266 IMABRAIN, Saint Anne Hospital Centre, Île-de-France, Paris, France
| | | | - Charlotte Rosso
- APHP-Urgences Cérébro-Vasculaires, Hôpital Pitié-Salpêtrière, Inserm U 1127, CNRS UMR 7225, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, Paris F-75013, France
| | - Romain Bourcier
- CHU Nantes, CNRS, INSERM, l'institut du thorax, Institut du thorax Nantes Université, 14 Lyon HCL, Nantes F-44000, France
| | - Omer Eker
- Neuroradiolology Department, Hospices Civils de Lyon, Lyon, France
| | - Jildaz Caroff
- Neuroradiolology Department, CHU Kremlin Bicêtre, Paris, France
| | - Bertrand Lapergue
- Department of Neuroradiology and Stroke Unit, Foch Hospital, Suresnes, France, University of Versailles Saint-Quentin-des-Yvelines, France
| | - Grégoire Boulouis
- Diagnostic and Interventional Neuroradiology Department, Tours University Hospital, INSERM UMR 1253 iBrain, 2 Bd Tonnellé, Centre Val de Loire, Tours, France.
| |
Collapse
|
7
|
Dallas J, Liu KQ, Wenger TA, Lin M, Ding L, Attenello FJ, Mack WJ. The effect of COVID-19 on treatment and outcomes following ischemic stroke: A national assessment. Clin Neurol Neurosurg 2023; 233:107982. [PMID: 37729801 DOI: 10.1016/j.clineuro.2023.107982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 09/11/2023] [Accepted: 09/14/2023] [Indexed: 09/22/2023]
Abstract
INTRODUCTION COVID-19 has had innumerable impacts on the healthcare system, both by worsening patient illness and impeding effective and efficient care. Further, COVID-19 has been tied to increased rates of ischemic stroke, particularly among young patients. We utilized a national database to assess associations of COVID-19 with thrombectomy rates, mortality, and discharge disposition among stroke patients. METHODS Patients were identified from the National Inpatient Sample (NIS, 2020). Inclusion criteria selected for adult ischemic stroke patients; those with venous thrombosis or unspecified cerebral infarction were excluded. Patients were stratified by presence or absence of COVID-19 diagnosis. Outcome variables included mechanical thrombectomy, in-hospital mortality, and discharge disposition. Additional patient demographics, hospital characteristics, and disease severity metrics were collected. Statistical analysis was performed via multivariable logistic regression and log-binary regression. RESULTS 54,368 patients were included in the study; 2116 (3.89%) were diagnosed with COVID-19. COVID-19 was associated with lower rates of mechanical thrombectomy (OR 0.94, p < 0.0001), higher rates of in-hospital mortality (OR 1.14, p < 0.0001), and unfavorable discharge disposition (OR 1.08, p < 0.0001), even when controlling for illness severity. Other relationships, such as a male predominance among stroke patients with COVID-19, were also identified. CONCLUSION This study identified a relationship between COVID-19 diagnosis and worse outcomes for each metric assessed, including mechanical thrombectomy rates, in-hospital mortality, and discharge disposition. Several factors might underly this, ranging from systemic/multisystem inflammation and worsened disease severity to logistical barriers to treatment caused by COVID-19. Further research is needed to determine causality of these findings.
Collapse
Affiliation(s)
- Jonathan Dallas
- Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
| | - Kristie Q Liu
- Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Talia A Wenger
- Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Michelle Lin
- Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Li Ding
- Departement of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - Frank J Attenello
- Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| | - William J Mack
- Department of Neurological Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
8
|
Bourcier R, Consoli A, Desilles JP, Labreuche J, Kyheng M, Desal H, Alias Q, Gory B, Dargazanli C, Janot K, Zhu F, Lapergue B, Marnat G. Temporal trends in results of endovascular treatment of anterior intracranial large cerebral vessel occlusion: A 7-year study. Eur Stroke J 2023; 8:655-666. [PMID: 37288701 PMCID: PMC10472952 DOI: 10.1177/23969873231180338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Accepted: 05/21/2023] [Indexed: 06/09/2023] Open
Abstract
BACKGROUND Technical improvements in devices, changes in angiographic grading scales and various confounding factors have made difficult the detection of the temporal evolution of angiographic and clinical results after endovascular treatment (EVT) for acute ischemic Stroke (AIS). We analyzed this evolution in time using the Endovascular Treatment in Ischemic Stroke (ETIS) registry. MATERIALS AND METHODS We analyzed the efficacy outcomes of EVT performed from January 2015 to January 2022, and modelized the temporal trends using mixed logistic regression models, further adjusted for age, intravenous thrombolysis prior to EVT, general anesthesia, occlusion site, balloon catheter use and the type of first-line EVT strategy. We assessed heterogeneity in temporal trends according to occlusion site, balloon catheter use, cardio embolic etiology, age (<80 years vs ⩾80 years) and first-line EVT strategy. RESULTS Among 6104 patients treated from 2015 to 2021, the rates of successful reperfusion (71.1%-89.6%) and of complete first pass effect (FPE) (4.6%-28.9%) increase, whereas the rates of patients with >3 EVT device passes (43.1%-17.5%) and favorable outcome (35.8%-28.9%) decrease significantly over time. A significant heterogeneity in temporal trends in successful reperfusion according to the first-line EVT strategy was found (p-het = 0.018). The temporal trend of increasing successful reperfusion rate was only significant in patients treated with contact aspiration in first-line (adjusted overall effect p = 0.010). CONCLUSION In this 7-year-old large registry of ischemic stroke cases treated with EVT, we observed a significant increase with time in the rate of recanalization whereas there was a tendency toward a decrease in the rate of favorable outcome over the same period.
Collapse
Affiliation(s)
- Romain Bourcier
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France
| | - Arturo Consoli
- Department of Diagnostic and Therapeutic Neuroradiology, Hôpital Foch Suresnes FR, University of Versailles Saint Quentin-en-Yvelines, Saint Quentin-en-Yvelines, France
| | - Jean-Philippe Desilles
- Department of Interventional Neuroradiology, Rothschild Foundation Hospital, INSERM unit 1148, Paris-Cité University, Paris, France
| | - Julien Labreuche
- EA 2694 - Santé publique: épidémiologie et qualité des soins, University of Lille, CHU Lille, Lille, France
| | - Maeva Kyheng
- EA 2694 - Santé publique: épidémiologie et qualité des soins, University of Lille, CHU Lille, Lille, France
| | - Hubert Desal
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nantes, Nantes, France
| | - Quentin Alias
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Rennes, Rennes, France
| | - Benjamin Gory
- IADI, University of Lorraine, INSERM U1254, Nancy, France
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France
| | - Cyril Dargazanli
- Department of Neuroradiology, Guy de Chauliac University Hospital, Montpellier, France
| | - Kévin Janot
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Tours, Tours, France
| | - François Zhu
- IADI, University of Lorraine, INSERM U1254, Nancy, France
- Department of Diagnostic and Therapeutic Neuroradiology, University Hospital of Nancy, Nancy, France
| | - Bertrand Lapergue
- Department of Neurology, Hôpital Foch Suresnes FR, University of Versailles Saint Quentin-en-Yvelines, France
| | - Gaultier Marnat
- Department of Diagnostic and Interventional Neuroradiology, University Hospital, Bordeaux, France
| |
Collapse
|
9
|
Stamm B, Royan R, Giurcanu M, Messe SR, Jauch EC, Prabhakaran S. Door-in-Door-out Times for Interhospital Transfer of Patients With Stroke. JAMA 2023; 330:636-649. [PMID: 37581671 PMCID: PMC10427946 DOI: 10.1001/jama.2023.12739] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/11/2023] [Accepted: 06/22/2023] [Indexed: 08/16/2023]
Abstract
Importance Treatments for time-sensitive acute stroke are not available at every hospital, often requiring interhospital transfer. Current guidelines recommend hospitals achieve a door-in-door-out time of no more than 120 minutes at the transferring emergency department (ED). Objective To evaluate door-in-door-out times for acute stroke transfers in the American Heart Association Get With The Guidelines-Stroke registry and to identify patient and hospital factors associated with door-in-door-out times. Design, Setting, and Participants US registry-based, retrospective study of patients with ischemic or hemorrhagic stroke from January 2019 through December 2021 who were transferred from the ED at registry-affiliated hospitals to other acute care hospitals. Exposure Patient- and hospital-level characteristics. Main Outcomes and Measures The primary outcome was the door-in-door-out time (time of transfer out minus time of arrival to the transferring ED) as a continuous variable and a categorical variable (≤120 minutes, >120 minutes). Generalized estimating equation (GEE) regression models were used to identify patient and hospital-level characteristics associated with door-in-door-out time overall and in subgroups of patients with hemorrhagic stroke, acute ischemic stroke eligible for endovascular therapy, and acute ischemic stroke transferred for reasons other than endovascular therapy. Results Among 108 913 patients (mean [SD] age, 66.7 [15.2] years; 71.7% non-Hispanic White; 50.6% male) transferred from 1925 hospitals, 67 235 had acute ischemic stroke and 41 678 had hemorrhagic stroke. Overall, the median door-in-door-out time was 174 minutes (IQR, 116-276 minutes): 29 741 patients (27.3%) had a door-in-door-out time of 120 minutes or less. The factors significantly associated with longer median times were age 80 years or older (vs 18-59 years; 14.9 minutes, 95% CI, 12.3 to 17.5 minutes), female sex (5.2 minutes; 95% CI, 3.6 to 6.9 minutes), non-Hispanic Black vs non-Hispanic White (8.2 minutes, 95% CI, 5.7 to 10.8 minutes), and Hispanic ethnicity vs non-Hispanic White (5.4 minutes, 95% CI, 1.8 to 9.0 minutes). The following were significantly associated with shorter median door-in-door-out time: emergency medical services prenotification (-20.1 minutes; 95% CI, -22.1 to -18.1 minutes), National Institutes of Health Stroke Scale (NIHSS) score exceeding 12 vs a score of 0 to 1 (-66.7 minutes; 95% CI, -68.7 to -64.7 minutes), and patients with acute ischemic stroke eligible for endovascular therapy vs the hemorrhagic stroke subgroup (-16.8 minutes; 95% CI, -21.0 to -12.7 minutes). Among patients with acute ischemic stroke eligible for endovascular therapy, female sex, Black race, and Hispanic ethnicity were associated with a significantly higher door-in-door-out time, whereas emergency medical services prenotification, intravenous thrombolysis, and a higher NIHSS score were associated with significantly lower door-in-door-out times. Conclusions and Relevance In this US registry-based study of interhospital transfer for acute stroke, the median door-in-door-out time was 174 minutes, which is longer than current recommendations for acute stroke transfer. Disparities and modifiable health system factors associated with longer door-in-door-out times are suitable targets for quality improvement initiatives.
Collapse
Affiliation(s)
- Brian Stamm
- Department of Neurology, University of Michigan, Ann Arbor
- Department of Neurology, Northwestern University, Chicago, Illinois
| | - Regina Royan
- Department of Emergency Medicine, University of Michigan, Ann Arbor
- Department of Emergency Medicine, Northwestern University, Chicago, Illinois
- Assistant Editor, JAMA Network Open
| | - Mihai Giurcanu
- Department of Public Health Sciences, University of Chicago, Chicago, Illinois
| | - Steven R. Messe
- Department of Neurology, University of Pennsylvania, Philadelphia
| | - Edward C. Jauch
- Department of Research, Mountain Area Health Education Center, Asheville, North Carolina
| | | |
Collapse
|
10
|
Ostos F, Rodríguez-López A, Martin Jiménez P, Sánchez CS, Martínez-Salio A, Ballenilla F, Lizasoaín I, Calleja-Castaño P. Use of Tenecteplase in Acute Ischemic Stroke in the Time of SARS-CoV-2. Neurohospitalist 2023; 13:266-271. [PMID: 37441211 PMCID: PMC10334066 DOI: 10.1177/19418744231167491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/15/2023] Open
Abstract
Tenecteplase (TNK) is a fibrinolytic drug that is administrated in a single bolus, recommended in eligible patients with acute ischemic stroke prior to mechanical thrombectomy. This study explores its usefulness in adverse situations, such as the SARS-CoV-2 pandemic. We conducted a retrospective study involving consecutive patients with suspected acute ischemic stroke treated either with intravenous fibrinolysis with alteplase during 2019 or with TNK (.25 mg/kg) between March 2020 and February 2021. A comparative analysis was made to compare patient treatment times and prognosis. A total of 117 patients treated with alteplase and 92 with TNK were included. No significant differences were observed in age, main vascular risk factors or previous treatments. The median National Institutes of Health Stroke Scale was 8 in the alteplase group and 10 in those treated with TNK (P = .13). Combined treatment with mechanical thrombectomy was performed in 47% in the alteplase group and 46.7% in the TNK group; Thrombolysis In Cerebral Infarction scale 2b-3 recanalization was achieved in 83% and 90.7%, respectively (P = .30). There was a decrease in onset-to-needle median time (165 min vs 140 min, P < .01) and no significant variations in door-needle median time. There was no significant difference in the incidence of symptomatic hemorrhagic transformation in mortality or functional independence at 3 months. The easier administration of TNK has improved the accessibility of fibrinolytic therapy, even in adverse circumstances, such as the COVID-19 pandemic. Its use appears to be safe and effective, even in patients who are not candidates for mechanical thrombectomy.
Collapse
Affiliation(s)
- Fernando Ostos
- Stroke Center, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain
- Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain
| | | | - Paloma Martin Jiménez
- Stroke Center, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Carmen Sánchez Sánchez
- Stroke Center, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Antonio Martínez-Salio
- Stroke Center, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Federico Ballenilla
- Department of Radiology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Ignacio Lizasoaín
- Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain
- Unidad de Investigación Neurovascular, Department of Pharmacology, Faculty of Medicine, Universidad Complutense, Madrid, Spain
| | - Patricia Calleja-Castaño
- Stroke Center, Department of Neurology, Hospital Universitario 12 de Octubre, Madrid, Spain
- Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain
| |
Collapse
|
11
|
Zhang W, Ling L, Li J, Li Y, Liu Y. Coronavirus disease 2019 and acute cerebrovascular events: a comprehensive overview. Front Neurol 2023; 14:1216978. [PMID: 37448747 PMCID: PMC10337831 DOI: 10.3389/fneur.2023.1216978] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Accepted: 06/12/2023] [Indexed: 07/15/2023] Open
Abstract
Since the Corona Virus Disease 2019 (COVID-19) pandemic, there has been increasing evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with acute cerebrovascular events such as cerebral infarction, cerebral hemorrhage, and cerebral venous thrombosis. Although the mechanism of cerebrovascular complications among COVID-19 patients has not been adequately elucidated, the hypercoagulable state, excessive inflammation and ACE-2-associated alterations in the renin-angiotensin-aldosterone system after SARS-CoV-2 infection probably play an essential role. In this overview, we discuss the possible mechanisms underlying the SARS-CoV-2 infection leading to acute cerebrovascular events and review the characteristics of COVID-19-related acute cerebrovascular events cases and treatment options available worldwide.
Collapse
Affiliation(s)
- Wanzhou Zhang
- Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
- The Third School of Clinical Medicine, Southern Medical University, Guangzhou, China
| | - Li Ling
- Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
| | - Jie Li
- Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
| | - Yudi Li
- Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
| | - Yajie Liu
- Department of Neurology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
| |
Collapse
|
12
|
Li G, Wang S, Wang C, Hao Y, Xiong Y, Ding Z, Zhao X. Intravenous thrombolysis for acute ischemic stroke during two COVID-19 outbreaks in China: Wuhan pandemic and Beijing pandemic. BMC Neurol 2023; 23:206. [PMID: 37231485 DOI: 10.1186/s12883-023-03211-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 04/14/2023] [Indexed: 05/27/2023] Open
Abstract
INTRODUCTION The COVID-19 pandemic has had an impact on the emergency department (ED). Door-to-needle time (DNT) could be prolonged for intravenous thrombolysis (IVT) treatment. We aimed to investigate the impact of two COVID-19 pandemics on the workflow of IVT in our neurovascular ED. METHOD We performed a retrospective analysis of patients who received IVT treatment in the neurovascular ED of Beijing Tiantan Hospital, Beijing, from January 20, 2020, to October 30, 2020, covering two COVID-19 pandemics in China. The time-based performances of IVT treatment including onset-to-arrival time, arrival-to-CT time, CT-to-needle time, door-to-needle time, and onset-to-needle time were recorded. Data on clinical characteristics and imaging information were also collected. RESULTS Four hundred forty patients that received IVT were enrolled in this study. The number of patients admitted to our neurovascular ED began to decrease in December 2019 and was the lowest in April 2020 (n = 95). Longer DNT (Wuhan pandemic: 49.00 [35.00, 64.00] min; Beijing pandemic: 55.00 [45.50, 77.00] min) interval delays were observed during the two pandemics (p = .016). More patients admitted during the two pandemics had an 'unknown' subtype (Wuhan pandemic: 21.8%; Beijing pandemic: 31.4%. p = .008). The percentage of the cardiac embolism subtype was higher during the Wuhan pandemic (20.0%) than during other periods. The median admission NIHSS score increased during the Wuhan pandemic and the Beijing pandemic (8.00 [4.00, 12.00], 7.00 [4.50, 14.00], respectively, p < .001). CONCLUSION The number of patients who received IVT decreased during the Wuhan pandemic. Higher admission NIHSS scores and prolonged DNT intervals were also observed during the Wuhan pandemic and the Beijing pandemic.
Collapse
Affiliation(s)
- Guangshuo Li
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Shang Wang
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- China National Clinical Research Center for Neurological Diseases, Fengtai District, No. 119 Nansihuanxilu, Beijing, 100070, China
| | - Chuanying Wang
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Yahui Hao
- China National Clinical Research Center for Neurological Diseases, Fengtai District, No. 119 Nansihuanxilu, Beijing, 100070, China
| | - Yunyun Xiong
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- China National Clinical Research Center for Neurological Diseases, Fengtai District, No. 119 Nansihuanxilu, Beijing, 100070, China
| | - Zeyu Ding
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
| | - Xingquan Zhao
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Fengtai District, No. 119 Nansihuanxilu, Beijing, 100070, China.
| |
Collapse
|
13
|
Nogueira RG, Etter K, Nguyen TN, Ikeme S, Wong C, Frankel M, Haussen DC, Del Rio C, McDaniel M, Sachdeva R, Devireddy CM, Al-Bayati AR, Mohammaden MH, Doheim MF, Pinheiro AC, Liberato B, Jillella DV, Bhatt NR, Khanna R. Changes in the care of acute cerebrovascular and cardiovascular conditions during the first year of the covid-19 pandemic in 746 hospitals in the USA: retrospective analysis. BMJ MEDICINE 2023; 2:e000207. [PMID: 37215071 PMCID: PMC10186086 DOI: 10.1136/bmjmed-2022-000207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Accepted: 03/16/2023] [Indexed: 05/24/2023]
Abstract
Objective To measure the impact of the covid-19 pandemic on admissions to hospital and interventions for acute ischemic stroke and acute myocardial infarction. Design A retrospective analysis. Setting 746 qualifying hospitals in the USA from the Premier Healthcare Database. Participants Patients aged 18 years and older who were admitted to hospital with a primary diagnosis of acute ischemic stroke or acute myocardial infarction between 1 March 2019 and 28 February 2021. Main outcome measures Relative changes in volumes were assessed for acute ischemic stroke and acute myocardial infarction hospital admissions as well as intravenous thrombolysis, mechanical thrombectomy, and percutaneous coronary intervention (overall and for acute myocardial infarction only) across the first year of the pandemic versus the prior year. Mortality in hospital and length of stay in hospital were also compared across the first year of the pandemic versus the corresponding period the year prior. These metrics were explored across the different pandemic waves. Results Among 746 qualifying hospitals, admissions to hospital were significantly reduced after the covid-19 pandemic compared with before the pandemic for acute ischemic stroke (-13.59% (95% confidence interval-13.77% to -13.41%) and acute myocardial infarction (-17.20% (-17.39% to -17.01%)), as well as intravenous thrombolysis (-9.47% (-9.99% to -9.02%)), any percutaneous coronary intervention (-17.89% (-18.06% to -17.71%)), and percutaneous coronary intervention for acute myocardial infarction (-14.36% (-14.59% to -14.12%)). During the first year of the pandemic versus the previous year, the odds of mortality in hospital for acute ischemic stroke were 9.00% higher (3.51% v 3.16%; ratio of the means 1.09 (95% confidence interval (1.03 to 1.15); P=0.0013) and for acute myocardial infarction were 18.00% higher (4.81% v 4.29%; ratio of the means 1.18 (1.13 to 1.23); P<0.0001). Conclusions We observed substantial decreases in admissions to hospital with acute ischemic stroke and acute myocardial infarction, but an increase in mortality in hospital throughout the first year of the pandemic. Public health interventions are needed to prevent these reductions in future pandemics.
Collapse
Affiliation(s)
- Raul G Nogueira
- Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, Pittsburgh, PA, USA
| | - Katherine Etter
- Global Provider and Payer Value Demonstration, Health Economics and Market Access, Johnson & Johnson, Raynham, MA, USA
| | - Thanh N Nguyen
- Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Shelly Ikeme
- Franchise Health Economics and Market Access, Johnson & Johnson, New Brunswick, NJ, USA
| | - Charlene Wong
- Global Provider and Payer Value Demonstration, Health Economics and Market Access, Johnson & Johnson, Raynham, MA, USA
| | - Michael Frankel
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
- Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA, USA
| | - Diogo C Haussen
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
- Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA, USA
| | - Carlos Del Rio
- Department of Medicine, Grady Memorial Hospital, Atlanta, GA, USA
| | - Michael McDaniel
- Department of Cardiology, Grady Memorial Hospital, Emory University School of Medicine, Atlanta, GA, USA
| | - Rajesh Sachdeva
- Department of Cardiology, Veterans Affairs Medical Center, Atlanta, GA, USA
| | - Chandan M Devireddy
- Department of Cardiology, Emory University Hospital Midtown, Emory University School of Medicine, Atlanta, GA, USA
| | - Alhamza R Al-Bayati
- Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, Pittsburgh, PA, USA
| | | | - Mohamed F Doheim
- Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, Pittsburgh, PA, USA
| | - Agostinho C Pinheiro
- Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, Pittsburgh, PA, USA
| | - Bernardo Liberato
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
- Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA, USA
| | - Dinesh V Jillella
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
- Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA, USA
| | - Nirav R Bhatt
- Department of Neurology, UPMC Stroke Institute, University of Pittsburgh, Pittsburgh, PA, USA
| | - Rahul Khanna
- Medical Device Epidemiology, Johnson and Johnson Medical Devices, New Brunswick, NJ, USA
| |
Collapse
|
14
|
Rivera R, Amudio C, Cruz JP, Brunetti E, Catalan P, Sordo JG, Echeverria D, Badilla L, Chamorro A, Gonzalez C, Ojeda H, Rodriguez C, Rogers N, Bravo L, Bravo F, Carrasco A, Gonzalez W, Lopez S, Orellana ML, Oportus M, Salazar A, Palacios G, Nguyen PT. The impact of a two-year long COVID-19 public health restriction program on mechanical thrombectomy outcomes in a stroke network. J Stroke Cerebrovasc Dis 2023; 32:107138. [PMID: 37087772 PMCID: PMC10106818 DOI: 10.1016/j.jstrokecerebrovasdis.2023.107138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2022] [Revised: 04/10/2023] [Accepted: 04/12/2023] [Indexed: 04/25/2023] Open
Abstract
OBJECTIVE The purpose of this study was to evaluate the impact of COVID-19 pandemic public health restrictions on our drip and ship mechanical thrombectomy program in Santiago Chile. MATERIALS AND METHODS This was a retrospective analysis of a prospectively collected database comparing two cohorts, one during a two-year period before COVID-19 and the second during the two years of the pandemic at our metropolitan stroke program. RESULTS A total of 100 patients were included in the pre COVID-19 cohort (cohort 1) and 121 in the COVID-19 cohort (cohort 2). There was a significant difference between cohorts, with older patients, different occlusion sites and higher door to arterial puncture time during the COVID-19 period. A non-significant trend for worse 90-day outcomes and higher mortality was present in cohort 2. There were no statistical differences in safety treatment parameters. CONCLUSIONS COVID-19 pandemic has had a measurable impact on our mechanical thrombectomy program. Results showed similarities to other reported Latin American series, where less robust health systems could adapt less efficiently compared to developed countries. After two years of public health restrictions, there were changes in the treatment population characteristics, delay in some internal management metrics and a non-significant trend to worse 90-day outcomes and higher mortality.
Collapse
Affiliation(s)
- Rodrigo Rivera
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile.
| | - Cristian Amudio
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Juan Pablo Cruz
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Enzo Brunetti
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Pascual Catalan
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Juan Gabriel Sordo
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Daniel Echeverria
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Lautaro Badilla
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Alex Chamorro
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Christian Gonzalez
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Héctor Ojeda
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Cristian Rodriguez
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Nicole Rogers
- Critical Care Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Loreto Bravo
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Fabian Bravo
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Alejandra Carrasco
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Walter Gonzalez
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Sofia Lopez
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Maria Luisa Orellana
- Neuroradiology Department, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Monica Oportus
- Anesthesia Unit, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Alejandro Salazar
- Anesthesia Unit, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Gerardo Palacios
- Anesthesia Unit, Instituto de Neurocirugia Dr. Alfonso Asenjo, Santiago - Chile
| | - Prof Thanh Nguyen
- Interventional neurology/ neuroradiology at Boston Medical Center (BMC), Boston MA - USA
| |
Collapse
|
15
|
Sedova P, Kent JA, Bryndziar T, Jarkovsky J, Tomek A, Sramek M, Skoda O, Sramkova T, Pokorová K, Littnerova S, Brown RD, Mikulik R. The decline in stroke hospitalization due to COVID-19 is unrelated to COVID-19 intensity. Eur J Neurol 2023; 30:943-950. [PMID: 36511840 PMCID: PMC9877601 DOI: 10.1111/ene.15664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 12/06/2022] [Accepted: 12/08/2022] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND PURPOSE During the coronavirus disease 2019 (COVID-19) pandemic many countries reported a decline in stroke volumes. The aim of this study was to analyze if the decline was related to the intensity of the COVID-19 pandemic. METHODS The first pandemic year (1 March 2020 to 28 February 2021) overall and during the three COVID-19 waves were compared with the preceding year. Volumes of acute ischaemic stroke (AIS), subarachnoid hemorrhage, intracerebral hemorrhage and recanalization treatments (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]) were obtained from the National Register of Reimbursed Health Services. Door-to-needle time, onset-to-door time and National Institutes of Health Stroke Scale at admission were obtained from the Registry of Stroke Care Quality. RESULTS During the pandemic year compared to the preceding year there were 26,453 versus 28,771 stroke admissions, representing an 8.8% decline (p < 0.001). The declines (-10%, -11%, -19%) appeared in COVID-19 waves (spring 2020, autumn 2020, winter 2021) except for an increase (2%) during summer 2020. Admissions for AIS declined by 10.2% (p < 0.001), whilst hemorrhagic stroke volumes were minimally decreased. The absolute volumes of IVT and MT decreased by 9.4% (p < 0.001) and 5.7% (p = 0.16), respectively. However, the proportions of ischaemic stroke patients receiving IVT (18% vs. 18%; p = 0.72) and MT (6% vs. 6%; p = 0.28) remained unchanged. CONCLUSIONS There was a decline in stroke admissions, but such decline was not related to COVID-19 incidence. The frequency of use of recanalization procedures (IVT, MT) and times (onset-to-door time, door-to-needle time) in AIS were preserved in the Czech Republic during the first year of the pandemic.
Collapse
Affiliation(s)
- Petra Sedova
- Department of NeurologyMayo ClinicRochesterMinnesotaUSA
- International Clinical Research CenterSt Anne's University HospitalBrnoCzech Republic
- Department of Internal Medicine and CardiologyUniversity Hospital Brno and Faculty of Medicine, Masaryk UniversityBrnoCzech Republic
- Department of NeurologySt Anne's University Hospital, and Faculty of Medicine, Masaryk UniversityBrnoCzech Republic
| | | | - Tomas Bryndziar
- International Clinical Research CenterSt Anne's University HospitalBrnoCzech Republic
- Department of NeurologySt Anne's University Hospital, and Faculty of Medicine, Masaryk UniversityBrnoCzech Republic
| | - Jiri Jarkovsky
- Institute of Health Information and Statistics of the Czech RepublicPragueCzech Republic
- Faculty of MedicineInstitute of Biostatistics and Analyses, Masaryk UniversityBrnoCzech Republic
| | - Ales Tomek
- Department of NeurologyCharles University in Prague, and Second Faculty of Medicine and Motol University HospitalPragueCzech Republic
| | - Martin Sramek
- Department of NeurologyCharles University in Prague, and Second Faculty of Medicine and Motol University HospitalPragueCzech Republic
| | - Ondrej Skoda
- Neurological Department and Stroke UnitJihlava HospitalJihlavaCzech Republic
- Department of NeurologyUniversity Hospital Kralovske Vinohrady and Charles University in PraguePragueCzech Republic
| | - Tereza Sramkova
- Department of NeurologyCharles University in Prague, and Second Faculty of Medicine and Motol University HospitalPragueCzech Republic
| | - Kateřina Pokorová
- Institute of Health Information and Statistics of the Czech RepublicPragueCzech Republic
- Faculty of MedicineInstitute of Biostatistics and Analyses, Masaryk UniversityBrnoCzech Republic
| | - Simona Littnerova
- Institute of Health Information and Statistics of the Czech RepublicPragueCzech Republic
- Faculty of MedicineInstitute of Biostatistics and Analyses, Masaryk UniversityBrnoCzech Republic
| | | | - Robert Mikulik
- International Clinical Research CenterSt Anne's University HospitalBrnoCzech Republic
- Department of NeurologySt Anne's University Hospital, and Faculty of Medicine, Masaryk UniversityBrnoCzech Republic
| |
Collapse
|
16
|
Mechanical Thrombectomy in Acute Ischemic Stroke COVID-19 and Non-COVID-19 Patients: A Single Comprehensive Stroke Center Study. LIFE (BASEL, SWITZERLAND) 2023; 13:life13010186. [PMID: 36676134 PMCID: PMC9866657 DOI: 10.3390/life13010186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/01/2022] [Accepted: 01/02/2023] [Indexed: 01/11/2023]
Abstract
Coronavirus disease 2019 (COVID-19) increases the risk for thromboembolic events, such as acute ischemic stroke (AIS). Mechanical thrombectomy (MT) is a therapy of choice in early diagnosed AIS; however, its success and outcomes in COVID-19 patients are contradictory. This study presented our experience with MT performed in COVID-19 patients compared to a control group. The retrospective analysis included patients with AIS who underwent MT from April 2021 to April 2022 at our institution. There were 13 COVID-19-related patients (with active or past COVID-19 infection) and 55 non-COVID-19 patients (negative COVID-19 status). We analyzed patients' baseline clinical and laboratory data, modified Thrombolysis in Cerebral Infarction (mTICI) scale, used 24 h follow-up CT findings, and modified the Rankin scale. The COVID-19 group had higher values of leukocytes, neutrophils, neutrophil/leukocyte ratios, ASL, ALT, LDH and CRP, and lower values of lymphocytes compared to the control group. The AIS mostly occurred in posterior circulation in the COVID-19 group, while anterior circulation was more affected in the control group. Treatment approach and successful reperfusion did not differ between groups. In conclusion, although differences in some clinical and laboratory parameters between COVID-19 and non-COVID-19 groups were found, the outcomes of mechanical thrombectomy were equal.
Collapse
|
17
|
Shinoda J, Ichimura S, Kanai R, Majima T, Azami S, Inoue K, Shirai T. Impact of JSS-PCS on the In-Hospital Workflow and Outcomes of Reperfusion Therapy for Acute Ischemic Stroke: Cases of a Metropolitan Secondary Emergency Facility. JOURNAL OF NEUROENDOVASCULAR THERAPY 2022; 17:37-46. [PMID: 37502129 PMCID: PMC10370527 DOI: 10.5797/jnet.oa.2022-0031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Accepted: 10/28/2022] [Indexed: 07/29/2023]
Abstract
Objective Protected code stroke has been widely introduced in the emergency medical system for acute stroke in the current coronavirus disease 2019 (COVID-19) pandemic. This study aims to confirm the effects of protected code stroke formulated by the Japan Stroke Society (JSS-PCS) on the quality and outcomes of reperfusion therapy for acute ischemic stroke (AIS), followed by evaluating its validity. Methods The subjects were 109 consecutive patients with AIS who underwent reperfusion therapy between January 2016 and July 2021, excluding in-hospital onset cases. Patients were classified according to the treatment date into the pre-COVID-19 (n = 82) and the with-COVID-19 (n = 27) groups. JSS-PCS was applied to all patients in the latter group. Statistical comparisons were made between groups on time indicators for initial treatment (onset-to-door time, door-to-imaging time [DTI], door-to-needle time [DTN], door-to-puncture time [DTP], door-to-reperfusion time, and puncture-to-reperfusion time [PTR]). The time indicator transition over the entire period was also evaluated by subgroup analysis. Subsequently, the outcomes at discharge were statistically compared between the two periods, followed by a subgroup comparison. Finally, univariate and multivariate analyses examined whether the application of JSS-PCS affected clinical outcomes. Results Slight delays were revealed in DTI, DTN, DTP, and PTR in the with-COVID-19 group with no statistical significance. The time indicators were delayed once entering the period of the COVID-19 pandemic and then shortened again. The outcomes at discharge tended to worsen slightly in the with-COVID-19 group with no significance. Subgroup analysis depicted a transient deterioration of outcomes early in the pandemic. Applying JSS-PCS did not significantly affect clinical outcomes in univariate and multivariate analyses. Conclusion Regarding reperfusion therapy at our facility, the introduction and application of JSS-PCS during the COVID-19 pandemic significantly affected neither time indicators nor outcomes. Infection control should be a top priority in the first medical practice for AIS in today's world, where COVID-19 shows no signs of termination.
Collapse
Affiliation(s)
- Jun Shinoda
- Department of Stroke, Eiju General Hospital, Tokyo, Japan
- Department of Neurosurgery, Eiju General Hospital, Tokyo, Japan
| | - Saeko Ichimura
- Department of Neurosurgery, Eiju General Hospital, Tokyo, Japan
| | - Ryuichi Kanai
- Department of Neurosurgery, Eiju General Hospital, Tokyo, Japan
| | - Takamasa Majima
- Department of Stroke, Eiju General Hospital, Tokyo, Japan
- Department of Neurology, Eiju General Hospital, Tokyo, Japan
| | - Shumpei Azami
- Department of Stroke, Eiju General Hospital, Tokyo, Japan
- Department of Neurology, Eiju General Hospital, Tokyo, Japan
| | - Kouji Inoue
- Department of Neurology, Eiju General Hospital, Tokyo, Japan
| | | |
Collapse
|
18
|
Blauenfeldt RA, Hedegaard JN, Kruuse C, Gaist D, Wienecke T, Modrau B, Damgaard D, Johnsen SP, Andersen G, Simonsen CZ. Quality in stroke care during the early phases of the COVID-19
pandemic: A nationwide study. Eur Stroke J 2022; 8:268-274. [PMID: 37012985 PMCID: PMC9732497 DOI: 10.1177/23969873221139695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Accepted: 11/01/2022] [Indexed: 12/13/2022] Open
Abstract
Introduction: Evidence-based early stroke care as reflected by fulfillment of process
performance measures, is strongly related to better patient outcomes after
stroke and transient ischemic attack (TIA). Detailed data on the resilience
of stroke care services during the COVID-19 pandemic are limited. We aimed
to examine the quality of early stroke care at Danish hospitals during the
early phases of the COVID-19 pandemic. Materials and methods: We extracted data from Danish national health registries in five time periods
(11 March, 2020–27 January, 2021) and compared these to a baseline
pre-pandemic period (13 March, 2019–10 March, 2020). Quality of early stroke
care was assessed as fulfilment of individual process performance measures
and as a composite measure (opportunity-based score). Results: A total of 23,054 patients were admitted with stroke and 8153 with a TIA
diagnosis in the entire period. On a national level, the opportunity-based
score (95% confidence interval [CI]) at baseline for ischemic patients was
81.1% (80.8–81.4), for intracerebral hemorrhage (ICH) 85.5% (84.3–86.6), and
for TIA 96.0% (95.3–96.1). An increase of 1.1% (0.1–2.2) and 1.5% (0.3–2.7)
in the opportunity-based score was observed during the first national
lockdown period for AIS and TIA followed by a decline of −1.3% (−2.2 to
−0.4) in the gradual reopening phase for AIS indicators. We found a
significant negative association between regional incidence rates and
quality-of-care in ischemic stroke patients implying that quality decreases
when admission rates increase. Conclusion: The quality of acute stroke/TIA care in Denmark remained high during the
early phases of the pandemic and only minor fluctuations occurred.
Collapse
Affiliation(s)
- Rolf A Blauenfeldt
- Department of Neurology, Aarhus
University Hospital, Aarhus, Denmark,Department of Clinical Medicine, Aarhus
University, Aarhus, Denmark,Rolf A Blauenfeldt Department of Neurology,
Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus 8200,
Denmark.
| | - Jakob N Hedegaard
- Danish Center for Clinical Health
Services Research, Department of Clinical Medicine, Aalborg University, Aalborg,
Denmark
| | - Christina Kruuse
- Department of Neurology, Copenhagen
University Hospital-Herlev Gentofte, Copenhagen, Denmark
| | - David Gaist
- Research Unit for Neurology, Odense
University Hospital, Odense, Denmark,University of Southern Denmark, Odense,
Denmark
| | - Troels Wienecke
- Department of Neurology, Zealand
University Hospital, Roskilde, Denmark
| | - Boris Modrau
- Department of Neurology, Aalborg
University Hospital, Aalborg, Denmark
| | - Dorte Damgaard
- Department of Neurology, Aarhus
University Hospital, Aarhus, Denmark,Department of Clinical Medicine, Aarhus
University, Aarhus, Denmark
| | - Søren P Johnsen
- Danish Center for Clinical Health
Services Research, Department of Clinical Medicine, Aalborg University, Aalborg,
Denmark
| | - Grethe Andersen
- Department of Neurology, Aarhus
University Hospital, Aarhus, Denmark,Department of Clinical Medicine, Aarhus
University, Aarhus, Denmark
| | - Claus Z Simonsen
- Department of Neurology, Aarhus
University Hospital, Aarhus, Denmark,Department of Clinical Medicine, Aarhus
University, Aarhus, Denmark
| |
Collapse
|
19
|
Lin V, Lele AV, Fong CT, Jannotta GE, Livesay S, Sharma M, Bonow RH, Town JA, Chou SH, Creutzfeldt CJ, Wahlster S. Impact of COVID-19 on neurocritical care delivery and outcomes in patients with severe acute brain injury - Assessing the initial response in the first US epicenter. J Clin Neurosci 2022; 106:135-140. [PMID: 36308868 PMCID: PMC9556940 DOI: 10.1016/j.jocn.2022.10.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2022] [Revised: 09/06/2022] [Accepted: 10/10/2022] [Indexed: 11/05/2022]
Abstract
To investigate the pandemic’s impact on critically ill patients with neurological emergencies, we compared care metrics and outcomes of patients with severe acute brain injury (SABI) before and during the initial COVID-19 surge at our institution. We included adult patients with SABI during two separate three-month time periods: 'pre-COVID vs COVID'. We further stratified the COVID cohort to characterize outcomes in patients requiring COVID-19 precautions (Patient Under Investigation, ‘PUI’). The primary endpoint was in-hospital mortality; secondary endpoints included length of stay (LOS), diagnostic studies performed, time to emergent decompressive craniectomies (DCHC), ventilator management, and end-of-life care. We included 394 patients and found the overall number of admissions for SABI declined by 29 % during COVID (pre-COVID n = 231 vs COVID, n = 163). Our primary outcome of mortality and most secondary outcomes were similar between study periods. There were more frequent extubation attempts (72.1 % vs 76 %) and the mean time to extubation was shorter during COVID (55.5 h vs 38.2 h). The ICU LOS (6.10 days vs 4.69 days) and hospital LOS (15.32 days vs 11.74 days) was shorter during COVID. More PUIs died than non-PUIs (51.7 % vs 11.2 %), but when adjusted for markers of illness severity, this was not significant. We demonstrate the ability to maintain a consistent care delivery for patients with SABI during the pandemic at our institution. PUIs represent a population with higher illness severity at risk for delays in care. Multicenter, longitudinal studies are needed to explore the impact of the pandemic on patients with acute neurological emergencies.
Collapse
Affiliation(s)
- Victor Lin
- Department of Neurology, Harborview Medical Center, University of Washington, Seattle, WA, USA.
| | - Abhijit V Lele
- Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA; Department of Neurological Surgery, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - Christine T Fong
- Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - Gemi E Jannotta
- Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - Sarah Livesay
- Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA; College of Nursing, Rush University, Chicago, IL, USA
| | - Monisha Sharma
- Department of Global Health, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - Robert H Bonow
- Department of Neurological Surgery, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - James A Town
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Washington, Seattle, WA, USA
| | - Sherry H Chou
- Ken and Ruth Davee Dept of Neurology, Northwestern University Feinberg School of Medicine, Chicago IL, USA
| | - Claire J Creutzfeldt
- Department of Neurology, Harborview Medical Center, University of Washington, Seattle, WA, USA
| | - Sarah Wahlster
- Department of Neurology, Harborview Medical Center, University of Washington, Seattle, WA, USA; Department of Anesthesiology and Pain Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA; Department of Neurological Surgery, Harborview Medical Center, University of Washington, Seattle, WA, USA
| |
Collapse
|
20
|
Riera-López N, Gaetano-Gil A, Martínez-Gómez J, Rodríguez-Rodil N, Fernández-Félix BM, Rodríguez-Pardo J, Cuadrado-Hernández C, Martínez-González EP, Villar-Arias A, Gutiérrez-Sánchez F, Busca-Ostolaza P, Montero-Ruiz E, Díez-Tejedor E, Zamora J, Fuentes-Gimeno B. The COVID-19 pandemic effect on the prehospital Madrid stroke code metrics and diagnostic accuracy. PLoS One 2022; 17:e0275831. [PMID: 36215281 PMCID: PMC9550046 DOI: 10.1371/journal.pone.0275831] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Accepted: 09/24/2022] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND Only very few studies have investigated the effect of the COVID-19 pandemic on the pre-hospital stroke code protocol. During the first wave, Spain was one of the most affected countries by the SARS-CoV-2 coronavirus disease pandemic. This health catastrophe overshadowed other pathologies, such as acute stroke, the leading cause of death among women and the leading cause of disability among adults. Any interference in the stroke code protocol can delay the administration of reperfusion treatment for acute ischemic strokes, leading to a worse patient prognosis. We aimed to compare the performance of the stroke code during the first wave of the pandemic with the same period of the previous year. METHODS This was a multicentre interrupted time-series observational study of the cohort of stroke codes of SUMMA 112 and of the ten hospitals with a stroke unit in the Community of Madrid. We established two groups according to the date on which they were attended: the first during the dates with the highest daily cumulative incidence of the first wave of the COVID-19 (from February 27 to June 15, 2020), and the second, the same period of the previous year (from February 27 to June 15, 2019). To assess the performance of the stroke code, we compared each of the pre-hospital emergency service time periods, the diagnostic accuracy (proportion of stroke codes with a final diagnosis of acute stroke out of the total), the proportion of patients treated with reperfusion therapies, and the in-hospital mortality. RESULTS SUMMA 112 activated the stroke code in 966 patients (514 in the pre-pandemic group and 452 pandemic). The call management time increased by 9% (95% CI: -0.11; 0.91; p value = 0.02), and the time on scene increased by 12% (95% CI: 2.49; 5.93; p value = <0.01). Diagnostic accuracy, and the proportion of patients treated with reperfusion therapies remained stable. In-hospital mortality decreased by 4% (p = 0.05). CONCLUSIONS During the first wave, a prolongation of the time "on the scene" of the management of the 112 calls, and of the hospital admission was observed. Prehospital diagnostic accuracy and the proportion of patients treated at the hospital level with intravenous thrombolysis or mechanical thrombectomy were not altered with respect to the previous year, showing the resilience of the stroke network and the emergency medical service.
Collapse
Affiliation(s)
- Nicolás Riera-López
- Stroke Commission, Emergency Medical Service of Madrid (SUMMA 112), Madrid, Spain
- * E-mail:
| | - Andrea Gaetano-Gil
- Clinical Biostatistics Unit, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain
| | - José Martínez-Gómez
- IT Department, Emergency Medical Service of Madrid (SUMMA 112), Madrid, Spain
| | | | - Borja M. Fernández-Félix
- Clinical Biostatistics Unit, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain
- CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
| | - Jorge Rodríguez-Pardo
- Department of Neurology and Stroke Centre, IdiPAZ Health Research Institute (La Paz University Hospital, Autonomous University of Madrid), Madrid, Spain
| | | | | | - Alicia Villar-Arias
- Management Department, Emergency Medical Service of Madrid (SUMMA 112), Madrid, Spain
| | | | - Pablo Busca-Ostolaza
- Management Department, Emergency Medical Service of Madrid (SUMMA 112), Madrid, Spain
| | | | - Exuperio Díez-Tejedor
- Department of Neurology and Stroke Centre, IdiPAZ Health Research Institute (La Paz University Hospital, Autonomous University of Madrid), Madrid, Spain
| | - Javier Zamora
- Clinical Biostatistics Unit, Ramón y Cajal University Hospital, IRYCIS, Madrid, Spain
- CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain
- WHO Collaborating Centre for Global Women’s Health, Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom
| | - Blanca Fuentes-Gimeno
- Department of Neurology and Stroke Centre, IdiPAZ Health Research Institute (La Paz University Hospital, Autonomous University of Madrid), Madrid, Spain
| | | |
Collapse
|
21
|
Rubens M, Saxena A, Ramamoorthy V, Ahmed MA, Zhang Z, McGranaghan P, Veledar E, McDermott M, De Los Rios La Rosa F. Hospital Outcomes among COVID-19 Hospitalizations with Acute Ischemic Stroke: Cross-Sectional Study Results from California State Inpatient Database. Brain Sci 2022; 12:brainsci12091177. [PMID: 36138913 PMCID: PMC9496747 DOI: 10.3390/brainsci12091177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 08/19/2022] [Accepted: 08/25/2022] [Indexed: 11/16/2022] Open
Abstract
Coronavirus disease 2019 (COVID-19) could be a risk factor for acute ischemic stroke (AIS) due to the altered coagulation process and hyperinflammation. This study examined the risk factors, clinical profile, and hospital outcomes of COVID-19 hospitalizations with AIS. This study was a retrospective analysis of data from California State Inpatient Database (SID) during 2019 and 2020. COVID-19 hospitalizations with age ≥ 18 years during 2020 and a historical cohort without COVID-19 from 2019 were included in the analysis. The primary outcomes studied were in-hospital mortality and discharge to destinations other than home. There were 91,420 COVID-19 hospitalizations, of which, 1027 (1.1%) had AIS. The historical control cohort included 58,083 AIS hospitalizations without COVID-19. Conditional logistic regression analysis showed that the odds of in-hospital mortality, discharge to destinations other than home, DVT, pulmonary embolism, septic shock, and mechanical ventilation were significantly higher among COVID-19 hospitalizations with AIS, compared to those without AIS. The odds of in-hospital mortality, DVT, pulmonary embolism, septic shock, mechanical ventilation, and respiratory failure were significantly higher among COVID-19 hospitalizations with AIS, compared to AIS hospitalizations without COVID-19. Although the prevalence of AIS was low among COVID-19 hospitalizations, it was associated with higher mortality and greater rates of discharges to destinations other than home.
Collapse
Affiliation(s)
- Muni Rubens
- Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA
| | - Anshul Saxena
- Center for Advanced Analytics, Baptist Health South Florida, Miami, FL 33176, USA
- Department of Neurology, Florida International University, Miami, FL 33199, USA
| | | | - Md Ashfaq Ahmed
- Center for Advanced Analytics, Baptist Health South Florida, Miami, FL 33176, USA
| | - Zhenwei Zhang
- Center for Advanced Analytics, Baptist Health South Florida, Miami, FL 33176, USA
| | - Peter McGranaghan
- Miami Cancer Institute, Baptist Health South Florida, Miami, FL 33176, USA
- Department of Internal Medicine and Cardiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 10117 Berlin, Germany
- Correspondence: (P.M.); (F.D.L.R.L.R.); Tel.: +49-030-45050 (P.M.); +1-(786)-596-3876 (F.D.L.R.L.R.)
| | - Emir Veledar
- Center for Advanced Analytics, Baptist Health South Florida, Miami, FL 33176, USA
- Department of Neurology, Florida International University, Miami, FL 33199, USA
| | - Michael McDermott
- Department of Neurology, Florida International University, Miami, FL 33199, USA
- Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL 33176, USA
| | - Felipe De Los Rios La Rosa
- Miami Neuroscience Institute, Baptist Health South Florida, Miami, FL 33176, USA
- Correspondence: (P.M.); (F.D.L.R.L.R.); Tel.: +49-030-45050 (P.M.); +1-(786)-596-3876 (F.D.L.R.L.R.)
| |
Collapse
|
22
|
Styczen H, Maus V, Goertz L, Köhrmann M, Kleinschnitz C, Fischer S, Möhlenbruch M, Mühlen I, Kallmünzer B, Dorn F, Lakghomi A, Gawlitza M, Kaiser D, Klisch J, Lobsien D, Rohde S, Ellrichmann G, Behme D, Thormann M, Flottmann F, Winkelmeier L, Gizewski ER, Mayer-Suess L, Boeckh-Behrens T, Riederer I, Klingebiel R, Berger B, Schlunz-Hendann M, Grieb D, Khanafer A, du Mesnil de Rochemont R, Arendt C, Altenbernd J, Schlump JU, Ringelstein A, Sanio VJM, Loehr C, Dahlke AM, Brockmann C, Reder S, Sure U, Li Y, Mühl-Benninghaus R, Rodt T, Kallenberg K, Durutya A, Elsharkawy M, Stracke P, Schumann MG, Bock A, Nikoubashman O, Wiesmann M, Henkes H, Mosimann PJ, Chapot R, Forsting M, Deuschl C. Mechanical thrombectomy for acute ischemic stroke in COVID-19 patients: multicenter experience in 111 cases. J Neurointerv Surg 2022; 14:858-862. [PMID: 35292572 PMCID: PMC8931799 DOI: 10.1136/neurintsurg-2022-018723] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2022] [Accepted: 03/02/2022] [Indexed: 12/02/2022]
Abstract
BACKGROUND Data on the frequency and outcome of mechanical thrombectomy (MT) for large vessel occlusion (LVO) in patients with COVID-19 is limited. Addressing this subject, we report our multicenter experience. METHODS A retrospective cohort study was performed of consecutive acute stroke patients with COVID-19 infection treated with MT at 26 tertiary care centers between January 2020 and November 2021. Baseline demographics, angiographic outcome and clinical outcome evaluated by the modified Rankin Scale (mRS) at discharge and 90 days were noted. RESULTS We identified 111 out of 11 365 (1%) patients with acute or subsided COVID-19 infection who underwent MT due to LVO. Cardioembolic events were the most common etiology for LVO (38.7%). Median baseline National Institutes of Health Stroke Scale score and Alberta Stroke Program Early CT Score were 16 (IQR 11.5-20) and 9 (IQR 7-10), respectively. Successful reperfusion (mTICI ≥2b) was achieved in 97/111 (87.4%) patients and 46/111 (41.4%) patients were reperfused completely. The procedure-related complication rate was 12.6% (14/111). Functional independence was achieved in 20/108 (18.5%) patients at discharge and 14/66 (21.2%) at 90 days follow-up. The in-hospital mortality rate was 30.6% (33/108). In the subgroup analysis, patients with severe acute COVID-19 infection requiring intubation had a mortality rate twice as high as patients with mild or moderate acute COVID-19 infection. Acute respiratory failure requiring ventilation and time interval from symptom onset to groin puncture were independent predictors for an unfavorable outcome in a logistic regression analysis. CONCLUSION Our study showed a poor clinical outcome and high mortality, especially in patients with severe acute COVID-19 infection undergoing MT due to LVO.
Collapse
Affiliation(s)
- Hanna Styczen
- Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - Volker Maus
- Department of Radiology, Neuroradiology and Nuclear Medicine, University Medical Center Langendreer, Bochum, Germany
| | - Lukas Goertz
- Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany
| | - Martin Köhrmann
- Department of Neurology and Center for Translational Neurosciences and Behavioral Sciences (CTNBS), University Hospital Essen, Essen, Germany
| | - Christoph Kleinschnitz
- Department of Neurology and Center for Translational Neurosciences and Behavioral Sciences (CTNBS), University Hospital Essen, Essen, Germany
| | - Sebastian Fischer
- Department of Radiology, Neuroradiology and Nuclear Medicine, University Medical Center Langendreer, Bochum, Germany
| | - Markus Möhlenbruch
- Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany
| | - Iris Mühlen
- Department of Neuroradiology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Bernd Kallmünzer
- Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
| | - Franziska Dorn
- Department of Neuroradiology, University Hospital Bonn, Bonn, Germany
| | - Asadeh Lakghomi
- Department of Neuroradiology, University Hospital Bonn, Bonn, Germany
| | - Matthias Gawlitza
- Institute and Policlinic of Neuroradiology, Universitatsklinikum Carl Gustav Carus, Dresden, Sachsen, Germany
| | - Daniel Kaiser
- Institute and Policlinic of Neuroradiology, Universitatsklinikum Carl Gustav Carus, Dresden, Sachsen, Germany
| | - Joachim Klisch
- Department of Diagnostic and Interventional Radiology and Neuroradiology, Helios General Hospital Erfurt, Erfurt, Germany
| | - Donald Lobsien
- Department of Diagnostic and Interventional Radiology and Neuroradiology, Helios General Hospital Erfurt, Erfurt, Germany
| | - Stefan Rohde
- Department of Radiology and Neuroradiology, Klinikum Dortmund gGmbH, Dortmund, Germany
| | - Gisa Ellrichmann
- Department of Neurology, Klinikum Dortmund gGmbH, Dortmund, Germany
| | - Daniel Behme
- Department of Neuroradiology, University Hospital Magdeburg, Magdeburg, Germany
| | | | - Fabian Flottmann
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
| | - Laurens Winkelmeier
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
| | - Elke R Gizewski
- Department of Neuroradiology, Medical University of Innsbruck, Innsbruck, Austria
| | - Lukas Mayer-Suess
- Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria
| | - Tobias Boeckh-Behrens
- Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Isabelle Riederer
- Department of Diagnostic and Interventional Neuroradiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - Randolf Klingebiel
- Department of Diagnostic and Interventional Neuroradiology, University Hospital OWL (Campus Bethel), Bielefeld, Germany
| | - Björn Berger
- Department of Diagnostic and Interventional Neuroradiology, University Hospital OWL (Campus Bethel), Bielefeld, Germany
| | - Martin Schlunz-Hendann
- Department of Radiology and Neuroradiology, Klinikum Duisburg - Sana Kliniken, Duisburg, Germany
| | - Dominik Grieb
- Department of Radiology and Neuroradiology, Klinikum Duisburg - Sana Kliniken, Duisburg, Germany
| | - Ali Khanafer
- Clinic for Neuroradiology, Klinikum Stuttgart, Stuttgart, Germany
| | | | - Christophe Arendt
- Institute of Neuroradiology, University Hospital Frankfurt and Goethe University, Frankfurt am Main, Germany
| | - Jens Altenbernd
- Department of Radiology and Neuroradiology, Gemeinschaftskrankenhaus Herdecke, Herdecke, Germany
| | - Jan-Ulrich Schlump
- Department of Neuropediatrics, Gemeinschaftskrankenhaus Herdecke, Herdecke, Germany
| | - Adrian Ringelstein
- Department of Radiology and Neuroradiology, Kliniken Maria Hilf, Moenchengladbach, Germany
| | | | - Christian Loehr
- Department of Radiology and Neuroradiology, Klinikum Vest, Recklinghausen, Germany
| | - Agnes Maria Dahlke
- Department of Radiology and Neuroradiology, Klinikum Vest, Recklinghausen, Germany
| | - Carolin Brockmann
- Department of Neuroradiology, University Medical Center Mainz, Mainz, Germany
| | - Sebastian Reder
- Department of Neuroradiology, University Medical Center Mainz, Mainz, Germany
| | - Ulrich Sure
- Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany
| | - Yan Li
- Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | | | - Thomas Rodt
- Department of Radiology, Klinikum Lueneburg, Lueneburg, Germany
| | - Kai Kallenberg
- Department of Neuroradiology, Klinikum Fulda, Fulda, Germany
| | | | | | - Paul Stracke
- Clinic for Radiology, University Hospital Muenster, Muenster, Germany
| | | | - Alexander Bock
- Department of Neuroradiology, Vivantes Klinikum Neukoelln, Berlin, Germany
| | - Omid Nikoubashman
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Aachen, Aachen, Germany
| | - Martin Wiesmann
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Aachen, Aachen, Germany
| | - Hans Henkes
- Clinic for Neuroradiology, Klinikum Stuttgart, Stuttgart, Germany
| | - Pascal J Mosimann
- Department of Neuroradiology, Alfried Krupp Hospital Ruttenscheid, Essen, Germany
| | - René Chapot
- Department of Neuroradiology, Alfried Krupp Hospital Ruttenscheid, Essen, Germany
| | - Michael Forsting
- Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| | - Cornelius Deuschl
- Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany
| |
Collapse
|
23
|
El‐Qushayri AE, Reda A, Dahy A, Azzam AY, Ghozy S. The impact of COVID 19 on the outcomes of thrombectomy in stroke patients: A systematic review and meta-analysis. Rev Med Virol 2022; 33:e2379. [PMID: 35833712 PMCID: PMC9349746 DOI: 10.1002/rmv.2379] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2022] [Revised: 04/22/2022] [Accepted: 07/05/2022] [Indexed: 01/28/2023]
Abstract
We aimed to conduct the current meta-analysis to provide better insight into the efficacy of mechanical thrombectomy (MT) in managing COVID-19 patients suffering from a stroke. An electronic search was conducted through eight databases for collecting the current evidence about the efficacy of MT in stroke patients with COVID-19 until 18 December 2021. The results were reported as the pooled prevalence rates and the odds ratios (ORs), with their corresponding 95% confidence intervals (CI). Out of 648 records, we included nine studies. The prevalence of stroke patients with COVID-19 who received MT treatment was with TICI ≥2b 79% (95%CI: 73-85), symptomatic intracranial haemorrhage 6% (95%CI: 3-11), parenchymal haematoma type 1, 11.1% (95%CI: 5-23), and mortality 29% (95%CI: 24-35). On further comparison of MT procedure between stroke patients with COVID 19 to those without COVID-19, we found no significant difference in terms of TICI ≥2b score (OR: 0.85; 95%CI: 0.03-23; p = 0.9). However, we found that stroke patients with COVID-19 had a significantly higher mortality rate than stroke patients without COVID-19 after MT procedure (OR: 2.99; 95%CI: 2.01-4.45; p < 0.001). Stroke patients with COVID-19 can be safely and effectively treated with MT, with comparable reperfusion and complication rates to those without the disease.
Collapse
Affiliation(s)
| | | | | | | | - Sherief Ghozy
- Department of NeuroradiologyMayo ClinicRochesterMinnesotaUSA,Nuffield Department of Primary Care Health Sciences and Department for Continuing Education (EBHC program)Oxford UniversityOxfordUK
| |
Collapse
|
24
|
Shokri H, Nahas NE, Basiony AE, Nguyen TN, Abdalkader M, Klein P, Lavados PM, Olavarría VV, Amaya P, Llanos-Leyton N, Brola W, Michał L, Fariña DEDM, Cardozo A, Caballero CD, Pedrozo F, Rahman A, Hokmabadi ES, Jalili J, Farhoudi M, Aref H, Roushdy T. Did COVID-19 impact stroke services? A multicenter study. Neurol Sci 2022; 43:4061-4068. [PMID: 35338400 PMCID: PMC8956331 DOI: 10.1007/s10072-022-06018-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2021] [Accepted: 03/13/2022] [Indexed: 11/29/2022]
Abstract
Background It has been reported that acute stroke services were compromised during COVID-19 due to various pandemic-related issues. We aimed to investigate these changes by recruiting centers from different countries. Methods Eight countries participated in this cross-sectional, observational, retrospective study by providing data from their stroke data base. We compared 1 year before to 1 year during COVID-19 as regards onset to door (OTD), door to needle (DTN), door to groin (DTG), duration of hospital stay, National Institute of Health Stroke Scale (NIHSS) at baseline, 24 h, and at discharge as well as modified Rankin score (mRS) on discharge and at 3 months follow-up. Results During the pandemic year, there was a reduction in the number of patients, median age was significantly lower, admission NIHSS was higher, hemorrhagic stroke increased, and OTD and DTG showed no difference, while DTN time was longer, rtPA administration was decreased, thrombectomy was more frequent, and hospital stay was shorter. mRS was less favorable on discharge and at 3 months. Conclusion COVID-19 showed variable effects on stroke services. Some were negatively impacted as the number of patients presenting to hospitals, DTN time, and stroke outcome, while others were marginally affected as the type of management.
Collapse
Affiliation(s)
- Hossam Shokri
- Faculty of Medicine, Ain Shams University, Cairo, Egypt.
| | | | - Ahmed El Basiony
- Neurology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Thanh N Nguyen
- Boston Medical Center, Boston University School of Medicine, Boston, USA
| | - Mohamad Abdalkader
- Boston Medical Center, Boston University School of Medicine, Boston, USA
| | - Piers Klein
- Boston Medical Center, Boston University School of Medicine, Boston, USA
| | - Pablo M Lavados
- Unidad de Neurología Vascular, Servicio de Neurología, Departamento de Neurología Y Psiquiatría Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile
| | - Verónica V Olavarría
- Unidad de Neurología Vascular, Servicio de Neurología, Departamento de Neurología Y Psiquiatría Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile
| | - Pablo Amaya
- Stroke Program, Neurology Department, Fundación Valle del Lili, Cali, Colombia
| | | | - Waldemar Brola
- Department of Neurology, Specialist Hospital Konskie, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
| | - Lipowski Michał
- Department of Neurology, Specialist Hospital Konskie, Collegium Medicum, Jan Kochanowski University, Kielce, Poland
| | | | - Analia Cardozo
- Stroke Unit of the Instituto de Previsión Social Central Hospital, Asunción, Paraguay
| | - Cesar David Caballero
- Stroke Unit of the Instituto de Previsión Social Central Hospital, Asunción, Paraguay
| | - Fatima Pedrozo
- Stroke Unit of the Instituto de Previsión Social Central Hospital, Asunción, Paraguay
| | | | | | - Javad Jalili
- Tabriz University of Medical Sciences, Tabriz, Iran
| | - Mehdi Farhoudi
- Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran
| | - Hany Aref
- Faculty of Medicine, Ain Shams University, Cairo, Egypt
| | - Tamer Roushdy
- Faculty of Medicine, Ain Shams University, Cairo, Egypt
| |
Collapse
|
25
|
Turner AC, Etherton MR. Utilization of Telestroke Prior to and Following the COVID-19 Pandemic. Semin Neurol 2022; 42:3-11. [PMID: 35576926 DOI: 10.1055/s-0041-1742181] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
For over two decades, telestroke has been utilized as a means for improving acute access to a stroke specialist when this expertise is otherwise unavailable. During this time, telestroke use has increased and improvements in care metrics have been widely reported. Several telestroke model variations are utilized; each has different workflow implications. A successful telestroke system should include adequate protocols and training, equipment, documentation system, and tracking of quality metrics. Upfront costs of needed technology and devices, credentialing hurdles, and limited reimbursement are all reported barriers to the utilization of telestroke. Emphasis on safety measures during the COVID-19 pandemic resulted in the dramatic upscaling of telehealth utilization, although overall stroke volumes declined in many areas in the early phases of the pandemic. Going forward, continued reduction in cost of required devices and broadband connections, increased use of automated and advanced analytical software, and a universal licensing and credentialing system are needed to continue the expansion of telestroke use.
Collapse
Affiliation(s)
- Ashby C Turner
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - Mark R Etherton
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
26
|
Medina-Rioja R, González-Calderón G, Saldívar-Dávila S, Estrada Saúl A, Gayón-Lombardo E, Somerville-Briones N, Calleja-Castillo JM. Grace Under Pressure: Resiliency of Quality Monitoring of Stroke Care During the Covid-19 Pandemic in Mexico City. Front Neurol 2022; 13:831735. [PMID: 35463140 PMCID: PMC9020365 DOI: 10.3389/fneur.2022.831735] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2021] [Accepted: 03/11/2022] [Indexed: 11/19/2022] Open
Abstract
Stroke is one of the leading causes of death and disability among adults worldwide. The World Health Organization (WHO) officially declared a COVID-19 pandemic on March 11, 2020. The first case in Mexico was confirmed in February 2020, subsequently becoming one of the countries most affected by the pandemic. In 2020, The National Institute of Neurology of Mexico started a Quality assurance program for stroke care, consisting of registering, monitoring and feedback of stroke quality measures through the RES-Q platform. We aim to describe changes in the demand for stroke healthcare assistance at the National Institute of Neurology and Neurosurgery during the pandemic and the behavior of stroke quality metrics during the prepandemic and the pandemic periods. For this study, we analyzed data for acute stroke patients registered in the RES-Q platform, in the prepandemic (November 2019 to February 2020) and pandemic (March-December 2020) periods in two groups, one prior to the pandemic. During the pandemic, there was an increase in the total number of assessed acute stroke patients at our hospital, from 474 to 574. The average time from the onset of symptoms to hospital arrival (Onset to Door Time—OTD) for all stroke patients (thrombolyzed and non-thrombolyzed) increased from 9 h (542 min) to 10.3 h (618.3 min) in the pandemic group. A total of 135 acute stroke patients were enrolled in this registry. We found the following results: Patients in both groups were studied with non-contrast computed tomography (NNCT), computed tomography angiography (CTA), magnetic resonance angiography (MRA), digital subtraction angiography (DSA) or more frequently in the pandemic period (early carotid imaging, Holter monitoring) as needed. Treatment for secondary prevention (antihypertensives, antiplatelets, statins) did not differ. Frequency of performing and documenting the performance of NIHSS scale at arrival and early dysphagia test improved. There was an increase in alteplase use from 21 to 42% (p = 0.03). There was a decrease in door to needle time (46 vs. 39 min p = 0.30). After the implementation of a stroke care protocol and quality monitoring system, acute stroke treatment in our institution has gradually improved, a process that was not thwarted during the COVID-19 pandemic.
Collapse
|
27
|
Quality of Care and Outcomes for Patients with Acute Ischemic Stroke and Transient Ischemic Attack During the COVID-19 Pandemic. J Stroke Cerebrovasc Dis 2022; 31:106455. [PMID: 35395471 PMCID: PMC8983051 DOI: 10.1016/j.jstrokecerebrovasdis.2022.106455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 03/14/2022] [Indexed: 01/09/2023] Open
Abstract
Background and Purpose Hospitalizations for acute ischemic stroke (AIS) and transient ischemic attack (TIA) decreased during the COVID-19 pandemic. We compared the quality of care and outcomes for patients with AIS/TIA before vs. during the COVID-19 pandemic across the United States Department of Veterans Affairs healthcare system. Methods This retrospective cohort study compared AIS/TIA care quality before (March–September 2019) vs. during (March-September 2020) the pandemic. Electronic health record data were used to identify patient characteristics, quality of care and outcomes. The without-fail rate was a composite measure summarizing whether an individual patient received all of the seven processes for which they were eligible. Mixed effects logistic regression modeling was used to assess differences between the two periods. Results A decrease in presentations occurred during the pandemic (N = 4360 vs. N = 5636 patients; p = 0.003) and was greater for patients with TIA (-30.4%) than for AIS (-18.7%). The without-fail rate improved during the pandemic (56.2 vs. before 50.1%). The use of high/moderate potency statins increased among AIS patients (OR 1.26 [1.06–1.48]) and remained unchanged among those with TIA (OR 1.04 [0.83,1.29]). Blood pressure measurement within 90-days of discharge was less frequent during the pandemic (57.8 vs. 89.2%, p < 0.001). Hypertension control decreased among patients with AIS (OR 0.73 [0.60–0.90]) and TIA (OR 0.72 [0.54-0.96]). The average systolic and diastolic blood pressure was 1.9/1.4 mmHg higher during the pandemic than before (p < 0.001). Compared to before, during the pandemic fewer AIS patients had a primary care visit (52.5% vs. 79.8%; p = 0.0001) or a neurology visit (27.9 vs. 41.1%; p = 0.085). Both 30- and 90-day unadjusted all-cause mortality rates were higher in 2020 (3.6% and 6.7%) vs. 2019 (2.9, 5.4%; p = 0.041 and p = 0.006); but these differences were not statistically significant after risk adjustment. Conclusions Overall quality of care for patients with AIS/TIA did not decline during the COVID-19 pandemic.
Collapse
|
28
|
Vargas A, Osteraas ND, Dafer RM, Cherian LJ, Song SY, Conners JJ. Acute telestroke evaluations during the COVID-19 pandemic. Neurol Sci 2022; 43:2211-2215. [PMID: 35064342 PMCID: PMC8782706 DOI: 10.1007/s10072-021-05826-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2021] [Accepted: 12/14/2021] [Indexed: 11/25/2022]
Abstract
We sought to analyze the effect of COVID-19 on telestroke requests and to characterize patients remotely evaluated for acute ischemic stroke (AIS) during this time. This study is a retrospective database review of all telestroke requests at one academic vascular neurology center telestroke network with seven remote sites in the USA between March 15 and April 30, 2020. Data were compared with historical cohort spanning same time frame in 2019 using parametric or nonparametric methods as appropriate. Among telestroke requests, characteristics of age, gender, race/ethnicity, National Institutes of Health Stroke Scale (NIHSS), primary diagnosis of AIS or transient ischemic attack (TIA), and number of patients receiving intravenous alteplase (IV-rtPA) and endovascular therapy (ET) were recorded. There was a 53% decrease in telestroke evaluation requests in 2020 from 2019 (p < 0.00001). Mean NIHSS in 2020 was 9.1 (SD ± 8.4) and mean NIHSS in 2019 was 7.2 (SD ± 7.3) (p = 0.122). Among patients with primary diagnosis of suspected AIS or TIA, mean age was 60.5 years in 2020 (SD ± 17.5) and mean age of 67.0 years in 2019 (SD ± 16.0) (p = 0.038). A significant lower number of telestroke evaluations were performed with a higher mean NIHSS overall and a lower mean age among AIS/TIA-suspected patients. Higher NIHSS and severity in all telestroke evaluations reflect neurological manifestations of AIS and mimics, possibly influenced by COVID-19. The younger age of those with suspected AIS or TIA reflects thrombotic complications in atypical stroke populations.
Collapse
Affiliation(s)
- Alejandro Vargas
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA.
| | - Nicholas D Osteraas
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA
| | - Rima M Dafer
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA
| | - Laurel J Cherian
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA
| | - Sarah Y Song
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA
| | - James J Conners
- Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison St. Suite 1121, Chicago, IL, 60612, USA
| |
Collapse
|
29
|
Miękisiak G, Pettersson SD, Szarek D, Morasiewicz P, Fercho J, Adamski S, Kipiński L, Szmuda T. Acute Stroke Care during COVID-19: National Data. Infect Dis Rep 2022; 14:198-204. [PMID: 35314654 PMCID: PMC8938781 DOI: 10.3390/idr14020024] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 03/08/2022] [Accepted: 03/10/2022] [Indexed: 02/05/2023] Open
Abstract
(1) Background: The pandemic of COVID-19 and subsequent lockdown strategies had a profound impact on many aspects of everyday life. During this time the world faced the unprecedented crisis of healthcare disrupting timely care delivery. This study was designed to evaluate the impact of the pandemic on the acute treatment of stroke in Poland. (2) Methods: The national data on hospitalizations with stroke as a primary diagnosis were obtained from the National Health Fund of Poland. Poisson regression was used to determine the significance of the change in hospital admissions. The differences between proportions were analyzed using the “N-1” Chi-squared test. (3) Results: During the COVID-19 period, the number of hospitalizations dropped by 8.28% with a monthly nadir of 22.02 in April. On a monthly scale during 2020, the greatest decrease was 22.02%. The thrombolysis ratio was also affected, with the highest monthly drop of 15.51% in November. The overall number of in-hospital deaths did not change. (4) Conclusions: The pandemic caused a serious disruption of the acute care of stroke. There is no evidence that the quality of care was seriously compromised.
Collapse
Affiliation(s)
- Grzegorz Miękisiak
- Institute of Medicine, University of Opole, 45-040 Opole, Poland;
- Correspondence: ; Tel.: +48-71-306-4607
| | - Samuel D. Pettersson
- Department of Neurosurgery, Medical University of Gdansk, 80-210 Gdansk, Poland; (S.D.P.); (J.F.); (T.S.)
| | - Dariusz Szarek
- Department of Neurosurgery, Marciniak’s Hospital, 54-049 Wrocław, Poland;
| | | | - Justyna Fercho
- Department of Neurosurgery, Medical University of Gdansk, 80-210 Gdansk, Poland; (S.D.P.); (J.F.); (T.S.)
| | - Stanisław Adamski
- Neurosurgery Department, Copernicus Hospital, 80-152 Gdansk, Poland;
| | - Lech Kipiński
- Department of Pathophysiology, Wroclaw Medical University, 50-367 Wroclaw, Poland;
| | - Tomasz Szmuda
- Department of Neurosurgery, Medical University of Gdansk, 80-210 Gdansk, Poland; (S.D.P.); (J.F.); (T.S.)
| |
Collapse
|
30
|
Stamm B, Huang D, Royan R, Lee J, Marquez J, Desai M. Pathomechanisms and Treatment Implications for Stroke in COVID-19: A Review of the Literature. Life (Basel) 2022; 12:life12020207. [PMID: 35207494 PMCID: PMC8877423 DOI: 10.3390/life12020207] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Revised: 01/17/2022] [Accepted: 01/25/2022] [Indexed: 11/25/2022] Open
Abstract
Stroke in patients with COVID-19 has received increasing attention throughout the global COVID-19 pandemic, perhaps due to the substantial disability and mortality that can result when the two conditions co-occur. We reviewed the existing literature and found that the proposed pathomechanism underlying COVID-19-associated ischemic stroke is broadly divided into the following three categories: vasculitis, endothelialitis, and endothelial dysfunction; hypercoagulable state; and cardioembolism secondary to cardiac dysfunction. There has been substantial debate as to whether there is a causal link between stroke and COVID-19. However, the distinct phenotype of COVID-19-associated strokes, with multivessel territory infarcts, higher proportion of large vessel occlusions, and cryptogenic stroke mechanism, that emerged in pooled analytic comparisons with non-COVID-19 strokes is compelling. Further, in this article, we review the various treatment approaches that have emerged as they relate to the proposed pathomechanisms. Finally, we briefly cover the logistical challenges, such as delays in treatment, faced by providers and health systems; the innovative approaches utilized, including the role of tele-stroke; and the future directions in COVID-19-associated stroke research and healthcare delivery.
Collapse
Affiliation(s)
- Brian Stamm
- Department of Neurology, School of Medicine, Northwestern University Feinberg, Chicago, IL 60611, USA; (D.H.); (J.L.)
- Correspondence: (B.S.); or (M.D.)
| | - Deborah Huang
- Department of Neurology, School of Medicine, Northwestern University Feinberg, Chicago, IL 60611, USA; (D.H.); (J.L.)
| | - Regina Royan
- Department of Emergency Medicine, School of Medicine, Northwestern University Feinberg, Chicago, IL 60611, USA;
| | - Jessica Lee
- Department of Neurology, School of Medicine, Northwestern University Feinberg, Chicago, IL 60611, USA; (D.H.); (J.L.)
| | - Joshua Marquez
- Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, NM 87144, USA;
| | - Masoom Desai
- Department of Neurology, School of Medicine, University of New Mexico, Albuquerque, NM 87144, USA;
- Correspondence: (B.S.); or (M.D.)
| |
Collapse
|
31
|
Al Hashmi A, von Bandemer S, Shuaib A, Mansour OY, Wassy M, Ozdemir AO, Farhoudi M, Al Jehani H, Khan A, John S, Saqqur M. Lessons learned in stroke care during COVID-19 pandemic and preparing for future pandemics in the MENA+ region: A consensus statement from the MENA+-SINO. J Neurol Sci 2022; 432:120060. [PMID: 34864375 PMCID: PMC8626147 DOI: 10.1016/j.jns.2021.120060] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2021] [Revised: 10/22/2021] [Accepted: 11/17/2021] [Indexed: 01/10/2023]
Abstract
Background COVID-19 pandemic has negatively impacted stroke care services at multiple levels. There was a decline in acute stroke admissions. Fewer interventions have been performed. Increased “door-to-needle times and “door-to-groin puncture” during this pandemic. These factors combined have led to declining in the favoured outcomes of stroke patients' globally. Yet this pandemic permits an opportunity for higher preparedness for future pandemics. Objectives and methods This paper aims to shed light on the main lessons learned in the field of stroke care during the first wave of COVID-19 pandemic. Here we are presenting proposals and initiatives for better preparedness in future similar emergencies. These proposals are based primarily on literature review of COVID-19 publications, as well as the first-hand experience gained during the first wave at the regional level. In addition to the consensus and collective ride of stroke experts in the Middle East North Africa Stroke and Interventional Neurotherapies Organization (MENA+-SINO) and interaction and collaboration with international stroke specialists from the Stroke World Organization (WSO), European Stroke Organization (ESO) and stroke and COVID-19 papers authors. Conclusion Stroke care is very complex, particularly in the initial hours after onset of symptoms. A successful outcome requires very close collaboration between clinical personnel from multiple specialties. Preparedness for future pandemics requires the improvement of care plans that allow for rapid assessment of stroke patients and ensuring that regular ‘mock exercises’ familiarize quintessential services that care for the stroke patients.
Collapse
Affiliation(s)
- Amal Al Hashmi
- Neuroscience Directorate, Khoula Hospital Ministry of Health of Oman, Muscat, Sultanate of Oman.
| | - Stephan von Bandemer
- Division of Health Service Research, Institute of Work and Technology, Gelsenkirchen, Germany.
| | - Ashfaq Shuaib
- Medicine and Neurology, Director Stroke Program, University of Alberta, Edmonton, AB, Canada.
| | - Ossama Yassin Mansour
- Alexandria Faculty of Medicine, Department of Neurology, Alexandria University, Egypt.
| | | | - Atilla Ozcan Ozdemir
- Interventional Neurology &Neurocritical Care Program, Eskisehir Osmangazi University, Turkey.
| | - Mehdi Farhoudi
- Neuroscience Research Center, Tabriz University, Islamic Republic of Iran.
| | - Hosam Al Jehani
- Department of Neurosurgery and Interventional Radiology, King Fahad Hospital of the University, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
| | - Adnan Khan
- Department of Medicine, Research Division, Weill Cornell Medicine-Qatar, Doha, Qatar.
| | - Seby John
- Neurology and Neurointerventional Surgery, Neurological Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates.
| | - Maher Saqqur
- University of Alberta Edmonton, Canada; Trillium Hospital, University of Toronto at Mississauga, Mississauga, ON. Canada.
| | | |
Collapse
|
32
|
Benali F, Stolze LJ, Rozeman AD, Dinkelaar W, Coutinho JM, Emmer BJ, Gons RAR, Yo LFS, van Tuijl JH, Boukrab I, van Dam-Nolen DHK, van den Wijngaard IR, Lycklama À Nijeholt GJ, de Laat KF, van Dijk LC, den Hertog HM, Flach HZ, Wermer MJH, van Walderveen MAA, Brouwers PJAM, Bulut T, Vermeer SE, Bernsen MLE, Uyttenboogaart M, Bokkers RPH, Boogaarts JD, de Leeuw FE, van der Worp HB, van der Schaaf IC, Schonewille WJ, Vos JA, Remmers MJM, Imani F, Dippel DWJ, van Zwam WH, Nederkoorn PJ, van Oostenbrugge RJ. Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands. BMC Neurol 2022; 22:22. [PMID: 35016635 PMCID: PMC8749107 DOI: 10.1186/s12883-021-02539-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Accepted: 12/20/2021] [Indexed: 12/03/2022] Open
Abstract
INTRODUCTION We investigated the impact of the Corona Virus Disease 2019 (COVID-19) pandemic and the resulting lockdown on reperfusion treatments and door-to-treatment times during the first surge in Dutch comprehensive stroke centers. Furthermore, we studied the association between COVID-19-status and treatment times. METHODS We included all patients receiving reperfusion treatment in 17 Dutch stroke centers from May 11th, 2017, until May 11th, 2020. We collected baseline characteristics, National Institutes of Health Stroke Scale (NIHSS) at admission, onset-to-door time (ODT), door-to-needle time (DNT), door-to-groin time (DGT) and COVID-19-status at admission. Parameters during the lockdown (March 15th, 2020 until May 11th, 2020) were compared with those in the same period in 2019, and between groups stratified by COVID-19-status. We used nationwide data and extrapolated our findings to the increasing trend of EVT numbers since May 2017. RESULTS A decline of 14% was seen in reperfusion treatments during lockdown, with a decline in both IVT and EVT delivery. DGT increased by 12 min (50 to 62 min, p-value of < 0.001). Furthermore, median NIHSS-scores were higher in COVID-19 - suspected or positive patients (7 to 11, p-value of 0.004), door-to-treatment times did not differ significantly when stratified for COVID-19-status. CONCLUSIONS During the first surge of the COVID-19 pandemic, a decline in acute reperfusion treatments and a delay in DGT was seen, which indicates a target for attention. It also appeared that COVID-19-positive or -suspected patients had more severe neurologic symptoms, whereas their EVT-workflow was not affected.
Collapse
Affiliation(s)
- Faysal Benali
- Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
| | - Lotte J Stolze
- Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands
| | - Anouk D Rozeman
- Department of Neurology and Radiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
| | - Wouter Dinkelaar
- Department of Neurology and Radiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands
| | - Jonathan M Coutinho
- Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands
| | - Bart J Emmer
- Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands
| | - Rob A R Gons
- Department of Neurology and Radiology, Catharina Hospital, Eindhoven, the Netherlands
| | - Lonneke F S Yo
- Department of Neurology and Radiology, Catharina Hospital, Eindhoven, the Netherlands
| | - Julia H van Tuijl
- Department of Neurology and Radiology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
| | - Issam Boukrab
- Department of Neurology and Radiology, Elisabeth TweeSteden Hospital, Tilburg, the Netherlands
| | - Dianne H K van Dam-Nolen
- Department of Neurology and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Ido R van den Wijngaard
- Department of Neurology and Radiology, Haaglanden Medical Center, The Hague, the Netherlands
| | | | - Karlijn F de Laat
- Department of Neurology and Radiology, Haga Hospital, The Hague, the Netherlands
| | - Lukas C van Dijk
- Department of Neurology and Radiology, Haga Hospital, The Hague, the Netherlands
| | - Heleen M den Hertog
- Department of Neurology and Radiology, Isala Hospital, Zwolle, the Netherlands
| | - H Zwenneke Flach
- Department of Neurology and Radiology, Isala Hospital, Zwolle, the Netherlands
| | - Marieke J H Wermer
- Department of Neurology and Radiology, Leiden University Medical Center, Leiden, the Netherlands
| | | | - Paul J A M Brouwers
- Department of Neurology and Radiology, Medisch Spectrum Twente, Enschede, the Netherlands
| | - Tomas Bulut
- Department of Neurology and Radiology, Medisch Spectrum Twente, Enschede, the Netherlands
| | - Sarah E Vermeer
- Department of Neurology and Radiology, Rijnstate Hospital, Arnhem, the Netherlands
| | | | - Maarten Uyttenboogaart
- Department of Neurology and Radiology, University Medical Center Groningen, Groningen, the Netherlands
| | - Reinoud P H Bokkers
- Department of Neurology and Radiology, University Medical Center Groningen, Groningen, the Netherlands
| | - Jeroen D Boogaarts
- Department of Neurosurgery and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
| | - Frank-Erik de Leeuw
- Department of Neurosurgery and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands
| | - H Bart van der Worp
- Department of Neurology and Neurosurgery and Radiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Irene C van der Schaaf
- Department of Neurology and Neurosurgery and Radiology, University Medical Center Utrecht, Utrecht, the Netherlands
| | - Wouter J Schonewille
- Department of Neurology and Radiology, Sint Antonius Hospital, Nieuwegein, the Netherlands
| | - Jan A Vos
- Department of Neurology and Radiology, Sint Antonius Hospital, Nieuwegein, the Netherlands
| | - Michel J M Remmers
- Department of Neurology and Radiology, Amphia Hospital, Breda, the Netherlands
| | - Farshad Imani
- Department of Neurology and Radiology, Amphia Hospital, Breda, the Netherlands
| | - Diederik W J Dippel
- Department of Neurology and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Wim H van Zwam
- Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
| | - Paul J Nederkoorn
- Department of Neurology and Radiology, Amsterdam UMC, Amsterdam, the Netherlands
| | - Robert J van Oostenbrugge
- Department of Neurology and Radiology & Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands
| |
Collapse
|
33
|
Malisch TW, Ansari SA, Duckwiler GR, Fargen KM, Hetts SW, Marden FA, Patsalides A, Schirmer CM, Brook A, Fraser JF. Cessation and resumption of elective neurointerventional procedures during the coronavirus disease 2019 pandemic and future pandemics. Interv Neuroradiol 2021; 27:30-35. [PMID: 34747645 PMCID: PMC8575972 DOI: 10.1177/15910199211035900] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
At the time of this writing, the coronavirus disease 2019 pandemic continues to be a global threat, disrupting usual processes, and protocols for delivering health care around the globe. There have been significant regional and national differences in the scope and timing of these disruptions. Many hospitals were forced to temporarily halt elective neurointerventional procedures with the first wave of the pandemic in the spring of 2020, in order to prioritize allocation of resources for acutely ill patients and also to minimize coronavirus disease 2019 transmission risks to non-acute patients, their families, and health care workers. This temporary moratorium on elective neurointerventional procedures is generally credited with helping to “flatten the curve” and direct scarce resources to more acutely ill patients; however, there have been reports of some delaying seeking medical care when it was in fact urgent, and other reports of patients having elective treatment delayed with the result of morbidity and mortality. Many regions have resumed elective neurointerventional procedures, only to now watch coronavirus disease 2019 positivity rates again climbing as winter of 2020 approaches. A new wave is now forecast which may have larger volumes of hospitalized coronavirus disease 2019 patients than the earlier wave(s) and may also coincide with a wave of patients hospitalized with seasonal influenza. This paper discusses relevant and practical elements of cessation and safe resumption of nonemergent neurointerventional services in the setting of a pandemic.
Collapse
Affiliation(s)
| | - Sameer A Ansari
- Departments of Radiology, Neurosurgery, and Neurology, Feinberg School of Medicine, 12244Northwestern University, USA
| | - Gary R Duckwiler
- Interventional Neuroradiology, David Geffen School of Medicine, University of California in Los Angeles, USA
| | - Kyle M Fargen
- Departments of Neurological Surgery and Radiology, 8676Wake Forest University, USA
| | - Steven W Hetts
- Departments of Radiology and Biomedical Engineering, University of California in San Francisco, USA
| | | | | | - Clemens M Schirmer
- Department of Neurosurgery and Neuroscience Institute, 2780Geisinger Health System and Geisinger Commonwealth School of Medicine, USA.,Research Institute of Neurointervention, Paracelsus Medical University, Austria
| | - Allan Brook
- Departments of Radiology and Neurosurgery, 2013Albert Einstein College of Medicine and Montefiore Medical Center, USA
| | - Justin F Fraser
- Departments of Neurological Surgery, Neurology, Radiology, and Neuroscience, University of Kentucky, USA
| |
Collapse
|
34
|
Zureigat H, Alhusban M, Cobia M. Mechanical Thrombectomy Outcomes in COVID-19 Patients With Acute Ischemic Stroke: A Narrative Review. Neurologist 2021; 26:261-267. [PMID: 34734904 PMCID: PMC8575107 DOI: 10.1097/nrl.0000000000000360] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
BACKGROUND Coronavirus disease 2019 (COVID-19) has been shown to associate with increased risk of thromboembolic events. Mechanical thrombectomy (MT) has long been used to effectively manage those with large-vessel occlusive (LVO) stroke and has similarly been implemented in the management of stroke in COVID-19 patients. REVIEW SUMMARY The COVID-19 pandemic took the health care sector by a storm. Thus, less is known about MT outcomes in this population and evidence suggesting poor outcomes postthrombectomy for COVID-19 patients is accumulating. We provide a narrative on some of the published studies on the outcomes of MT in COVID-19 patients with LVO between March 2020 and February 2021. A description of patient characteristics, risk factors, COVID-19 infection severity, stroke features and thrombectomy success in this population is also presented as data from several studies show that LVO in COVID-19 patients may have some distinguishing characteristics that make management more challenging. CONCLUSIONS The effect of COVID-19 on the long-term prognosis of stroke patients after thrombectomy is yet to be determined. The accumulating evidence from current studies indicates a negative impact of COVID-19 on outcomes in acute ischemic stroke patients who receive MT, irrespective of timely, successful angiographic recanalization. This review may help alert clinicians of some of the COVID-19-specific postthrombectomy challenges.
Collapse
Affiliation(s)
| | - Muna Alhusban
- School of Medicine, University of Jordan, Amman, Jordan
| | - Miles Cobia
- the Department of Neurology, Grandview Medical Center, Birmingham, AL
| |
Collapse
|
35
|
Yu AY, Lee DS, Vyas MV, Porter J, Rashid M, Fang J, Austin PC, Hill MD, Kapral MK. Emergency Department Visits, Care, and Outcome After Stroke and Myocardial Infarction During the COVID-19 Pandemic Phases. CJC Open 2021; 3:1230-1237. [PMID: 34723166 PMCID: PMC8548659 DOI: 10.1016/j.cjco.2021.06.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Accepted: 06/02/2021] [Indexed: 12/11/2022] Open
Abstract
Background It is not known if initial reductions in hospitalization for stroke and myocardial infarction early during the coronavirus disease–2019 pandemic were followed by subsequent increases. We describe the rates of emergency department visits for stroke and myocardial infarction through the pandemic phases. Methods We used linked administrative data to compare the weekly age- and sex-standardized rates of visits for stroke and myocardial infarction in Ontario, Canada in the first 9 months of 2020 to the mean baseline rates (2015-2019) using rate ratios (RRs) and 95% confidence intervals (CIs). We compared care and outcomes by pandemic phases (pre-pandemic was January-March, lockdown was March-May, early reopening was May-July, and late reopening was July-September). Results We identified 15,682 visits in 2020 for ischemic stroke (59.2%; n = 9279), intracerebral hemorrhage (12.2%; n = 1912), or myocardial infarction (28.6%; n = 4491). The weekly rates for stroke visits in 2020 were lower during the lockdown and early reopening than at baseline (RR 0.76, 95% CI [0.66, 0.87] for the largest weekly decrease). The weekly rates for myocardial infarction visits were lower during the lockdown only (RR 0.61, 95% CI [0.46, 0.77] for the largest weekly decrease), and there was a compensatory increase in visits following reopening. Ischemic stroke 30-day mortality was increased during the lockdown phase (11.5% pre-coronavirus disease; 12.2% during lockdown; 9.2% during early reopening; and 10.6% during late reopening, P = 0.015). Conclusion After an initial reduction in visits for stroke and myocardial infarction, there was a compensatory increase in visits for myocardial infarction. The death rate after ischemic stroke was higher during the lockdown than in other phases.
Collapse
Affiliation(s)
- Amy Y.X. Yu
- Department of Medicine (Neurology), University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- ICES, Toronto, Ontario, Canada
- Corresponding author: Dr Amy Y.X. Yu, Neurologist, Department of Medicine (Neurology), University of Toronto, Sunnybrook Health Sciences Centre, Office A-455, 2075 Bayview Ave, Toronto, Ontario M4N 3M5, Canada. Tel.: +1-416-480-4866; fax: +1-416-480-5753.
| | - Douglas S. Lee
- ICES, Toronto, Ontario, Canada
- Department of Medicine (Cardiology), University of Toronto–University Health Network, Toronto, Ontario, Canada
| | - Manav V. Vyas
- Department of Medicine (Neurology), University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- ICES, Toronto, Ontario, Canada
| | | | | | | | | | - Michael D. Hill
- Department of Clinical Neurosciences, Community Health Sciences, and Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada
| | - Moira K. Kapral
- ICES, Toronto, Ontario, Canada
- Department of Medicine (General Internal Medicine), University of Toronto–University Health Network, Toronto, Ontario, Canada
| |
Collapse
|
36
|
Leslie-Mazwi TM, Srivatanakul K. Coronavirus disease 2019 and stroke. Interv Neuroradiol 2021; 27:13-18. [PMID: 34670419 PMCID: PMC8575978 DOI: 10.1177/15910199211035920] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The multisystem nature of coronavirus disease 2019 has become increasingly clear over the course of the pandemic. Both the neurological and vascular systems are affected, impacting acute stroke. This impact can be conceptualised as direct and indirect effects of the disease. The direct effects of coronavirus disease 2019 on stroke are thought to relate to receptor-mediated tissue invasion and the marked inflammatory response to the presence of the virus. These effects include coagulopathies, endotheliitis, systemic inflammation and atherosclerotic plaque instability, with possibly long-term cardiovascular effects. The indirect effects impact all aspects of stroke care delivery. These extend far beyond the direct effects of coronavirus disease 2019, and represent an essential focus for stroke systems of care. In this article, we detail the impact of coronavirus disease 2019 on acute stroke.
Collapse
|
37
|
Aggour M, Tran Chi C, Fiehler J. Patient prioritization and management during the COVID-19 pandemic. Interv Neuroradiol 2021; 27:19-23. [PMID: 34668803 PMCID: PMC8575979 DOI: 10.1177/15910199211035302] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
The coronavirus disease 2019 (COVID-19) pandemic affected the healthcare system in a major way generally. Healthcare re-organization of resources and manpower, establishing management protocols and specific patients’ pathways are all evolving with the continuously changing situation. Neuro-vascular management and its re-organization are part of these global measures to cope with this pandemic in a way to establish less risky patients’ pathways, help in patients’ triage, protecting the staff by introducing training and applying safety measures and to manage neuro-vascular emergencies and elective activity. We here describe the situation of the pandemic affecting neuro-vascular interventions and propose our recommendations for patients’ triage, resources management and organization, remote solutions and preparations for any future waves.
Collapse
Affiliation(s)
- Mohamed Aggour
- Department of Interventional Neuroradiology, 112001The Royal London Hospital, UK
| | - Cuong Tran Chi
- Stroke International Services (S.I.S) General Hospital, Vietnam
| | - Jens Fiehler
- Department of Diagnostic and Interventional Neuroradiology, UMC Hamburg-Eppendorf, Germany
| |
Collapse
|
38
|
Jillella DV, Philbrook B, Ortolani E, Grossberg JA, Stani T, Samuels O, Pimentel C, Harrison A, Polu AR, Siegel BI, McCullough I, Cawley M, Nahab F. Successful Endovascular Therapy in COVID-19 Associated Pediatric Ischemic Stroke. J Stroke Cerebrovasc Dis 2021; 30:106152. [PMID: 34649038 PMCID: PMC8491968 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 09/25/2021] [Accepted: 09/29/2021] [Indexed: 12/12/2022] Open
Abstract
Cerebrovascular diseases attributed to coronavirus disease 2019 (COVID-19) are uncommon but can result in devastating outcomes. Pediatric acute ischemic strokes are themselves rare and with very few large vessel occlusion related acute ischemic strokes attributed to COVID-19 described in the literature as of date. COVID-19 pandemic has contributed to acute stroke care delays across the world and with pediatric endovascular therapy still in its infancy, it poses a great challenge in facilitating good outcomes in children presenting with acute ischemic strokes in the setting of COVID-19. We present a pediatric patient who underwent endovascular therapy for an internal carotid artery occlusion related acute ischemic stroke in the setting of active COVID-19 and had an excellent outcome thanks to a streamlined stroke pathway involving the vascular neurology, neuro-interventional, neurocritical care, and anesthesiology teams.
Collapse
Affiliation(s)
- Dinesh V Jillella
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Bryan Philbrook
- Department of Pediatrics, Pediatric Neurology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Elissa Ortolani
- Department of Pediatrics, Pediatric Neurology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Jonathan A Grossberg
- Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.
| | - Tristan Stani
- Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.
| | - Owen Samuels
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.
| | - Cederic Pimentel
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States; Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.
| | - Amy Harrison
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States
| | - Ashok R Polu
- Department of Neurology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Benjamin I Siegel
- Department of Pediatrics, Pediatric Neurology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Ian McCullough
- Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, United States.
| | - Michael Cawley
- Department of Neurosurgery, Emory University School of Medicine, Atlanta, GA, United States.
| | - Fadi Nahab
- Department of Neurology & Pediatrics, Emory University School of Medicine, Atlanta, GA, United States.
| |
Collapse
|
39
|
Qureshi AI, Baskett WI, Huang W, Ishfaq MF, Naqvi SH, French BR, Siddiq F, Gomez CR, Shyu CR. Utilization and Outcomes of Acute Revascularization Treatment in Ischemic Stroke Patients with SARS-CoV-2 Infection. J Stroke Cerebrovasc Dis 2021; 31:106157. [PMID: 34689049 PMCID: PMC8498748 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106157] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 09/29/2021] [Accepted: 10/01/2021] [Indexed: 12/20/2022] Open
Abstract
Objectives Acute ischemic stroke patients with severe acute respiratory syndrome coronavirus maybe candidates for acute revascularization treatments (intravenous thrombolysis and/or mechanical thrombectomy). Materials and Methods We analyzed the data from 62 healthcare facilities to determine the odds of receiving acute revascularization treatments in severe acute respiratory syndrome coronavirus infected patients and determined the odds of composite of death and non-routine discharge with severe acute respiratory syndrome coronavirus infected and non-infected patients undergoing acute revascularization treatments after adjusting for potential confounders. Results Acute ischemic stroke patients with severe acute respiratory syndrome coronavirus infection were significantly less likely to receive acute revascularization treatments (odds ratio 0.6, 95% confidence interval 0.5–0.8, p = 0.0001). Among ischemic stroke patients who received acute revascularization treatments, severe acute respiratory syndrome coronavirus infection was associated with increased odds of death or non-routine discharge (odds ratio 3.0, 95% confidence interval 1.8–5.1). The higher odds death or non-routine discharge (odds ratio 2.1, 95% confidence interval 1.9–2.3) with severe acute respiratory syndrome coronavirus infection were observed in all ischemic stroke patients without any modifying effect of acute revascularization treatments (interaction term for death (p = 0.9) or death or non-routine discharge (p = 0.2). Conclusions Patients with acute ischemic stroke with severe acute respiratory syndrome coronavirus infection were significantly less likely to receive acute revascularization treatments. Severe acute respiratory syndrome coronavirus infection was associated with a significantly higher rate of death or non-routine discharge among acute ischemic stroke patients receiving revascularization treatments.
Collapse
Affiliation(s)
- Adnan I Qureshi
- Zeenat Qureshi Stroke Insititute and Department of Nuerology, University of Missouri, One Hospital Dr., CE507, Columbia MO 65212, USA
| | - William I Baskett
- Institute for Data Science and Informatics, University of Missouri, Columbia, MO, USA
| | - Wei Huang
- Zeenat Qureshi Stroke Insititute and Department of Nuerology, University of Missouri, One Hospital Dr., CE507, Columbia MO 65212, USA.
| | | | - S Hasan Naqvi
- Department of Medicine, University of Missouri, Columbia, MO, USA
| | - Brandi R French
- Department of Neurology, University of Missouri, Columbia, MO, USA
| | - Farhan Siddiq
- Division of Neurosurgery, University of Missouri, Columbia, MO, USA
| | - Camilo R Gomez
- Department of Neurology, University of Missouri, Columbia, MO, USA
| | - Chi-Ren Shyu
- Institute for Data Science and Informatics, University of Missouri, Columbia, MO, USA; Department of Medicine, University of Missouri, Columbia, MO, USA; Department of Electrical Engineering and Computer Science, University of Missouri, Columbia, MO, USA
| |
Collapse
|
40
|
Raymaekers V, Demeestere J, Bellante F, De Blauwe S, De Raedt S, Dusart A, Jodaitis L, Lemmens R, Loos C, Noémie L, Rutgers MP, Vandervorst F, Vanhooren G, Yperzeele L, Nogueira RG, Nguyen TN, Vanacker P. The impact of COVID-19 on acute stroke care in Belgium. Acta Neurol Belg 2021; 121:1251-1258. [PMID: 34148220 PMCID: PMC8214455 DOI: 10.1007/s13760-021-01726-x] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 06/10/2021] [Indexed: 02/06/2023]
Abstract
A worldwide decline in stroke hospitalizations during the COVID-19 pandemic has been reported. Information on stroke care during the pandemic in Belgium is lacking. This study aims to analyze the impact of COVID-19 on acute stroke care in eight Belgian stroke centers. This Belgian study is part of an international observational and retrospective study in 70 countries and 457 stroke centers. We compared volumes of COVID-19 and stroke hospitalizations, intravenous thrombolysis and endovascular treatment rates, acute treatment time intervals and functional outcome at 90 days during the first wave of the pandemic to two control intervals (March–May 2019 and December–February 2020). From March 2020 to May 2020, 860 stroke patients were hospitalized. In the same time period, 2850 COVID-19 patients were admitted, of which 37 (1.3%) were diagnosed with a stroke. Compared to the months prior to the pandemic and the same time epoch one year earlier, stroke hospitalizations were reduced (relative difference 15.9% [p = 0.03] and 14.5% [p = 0.05], respectively). Despite a reduction in absolute volumes, there was no difference in the monthly proportion of thrombolysis or endovascular treatment provided to the overall stroke hospitalizations. Acute treatment time metrics did not change between COVID-19 pandemic and control time epochs. We found no difference in 90-day functional outcomes nor in mortality after stroke between patients admitted during the pandemic versus control periods. We found a decline in the volume of stroke hospitalizations during the first wave of the COVID-19 pandemic in Belgium. Stroke care quality parameters remained unchanged.
Collapse
Affiliation(s)
- Vincent Raymaekers
- Department of Neurology, Groeninge Hospital, Kortrijk, Belgium.
- Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium.
| | - Jelle Demeestere
- Department of Neurology, Leuven University Hospital, Leuven, Belgium
| | - Flavio Bellante
- Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium
| | - Sofie De Blauwe
- Department of Neurology, Sint-Jan Hospital Bruges-Ostend, Bruges, Belgium
| | - Sylvie De Raedt
- Department of Neurology, University Hospital Brussels, Jette, Belgium
- Center of Neurosciences, University of Brussels, Brussels, Belgium
| | - Anne Dusart
- Department of Neurology, Hôpital Civil Marie Curie, Charleroi, Belgium
| | - Lise Jodaitis
- Department of Neurology, Erasmus Hospital, Brussels, Belgium
| | - Robin Lemmens
- Department of Neurology, Leuven University Hospital, Leuven, Belgium
| | - Caroline Loos
- Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium
- Department of Neurology, Antwerp University Hospital, Edegem, Belgium
| | - Ligot Noémie
- Department of Neurology, Erasmus Hospital, Brussels, Belgium
| | | | - Fenne Vandervorst
- Department of Neurology, University Hospital Brussels, Jette, Belgium
- Center of Neurosciences, University of Brussels, Brussels, Belgium
| | - Geert Vanhooren
- Department of Neurology, Sint-Jan Hospital Bruges-Ostend, Bruges, Belgium
| | - Laetitia Yperzeele
- Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium
- Department of Neurology, Antwerp University Hospital, Edegem, Belgium
| | - Raul G Nogueira
- Department of Neurology, Grady Memorial Hospital, Emory University, Atlanta, GA, USA
| | - Thanh N Nguyen
- Department of Neurology, Radiology, Boston Medical Center, Boston University School of Medicine, Boston, USA
| | - Peter Vanacker
- Department of Neurology, Groeninge Hospital, Kortrijk, Belgium
- Faculty of Medicine and Health Sciences, Antwerp University, Antwerp, Belgium
- Department of Neurology, Antwerp University Hospital, Edegem, Belgium
| |
Collapse
|
41
|
Romoli M, Eusebi P, Forlivesi S, Gentile M, Giammello F, Piccolo L, Giannandrea D, Vidale S, Longoni M, Paolucci M, Hsiao J, Sayles E, Yeo LLL, Kristoffersen ES, Chamorro A, Jiao L, Khatri P, Tsivgoulis G, Paciaroni M, Zini A. Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models. Int J Stroke 2021; 16:771-783. [PMID: 34427480 PMCID: PMC8521356 DOI: 10.1177/17474930211041202] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Accepted: 08/03/2021] [Indexed: 12/22/2022]
Abstract
BACKGROUND The effect of the COVID pandemic on stroke network performance is unclear, particularly with consideration of drip&ship vs. mothership models. AIMS We systematically reviewed and meta-analyzed variations in stroke admissions, rate and timing of reperfusion treatments during the first wave COVID pandemic vs. the pre-pandemic timeframe depending on stroke network model adopted. SUMMARY OF FINDINGS The systematic review followed registered protocol (PROSPERO-CRD42020211535), PRISMA and MOOSE guidelines. We searched MEDLINE, EMBASE, and CENTRAL until 9 October 2020 for studies reporting variations in ischemic stroke admissions, treatment rates, and timing in COVID (first wave) vs. control-period. Primary outcome was the weekly admission incidence rate ratio (IRR = admissions during COVID-period/admissions during control-period). Secondary outcomes were (i) changes in rate of reperfusion treatments and (ii) time metrics for pre- and in-hospital phase. Data were pooled using random-effects models, comparing mothership vs. drip&ship model. Overall, 29 studies were included in quantitative synthesis (n = 212,960). COVID-period was associated with a significant reduction in stroke admission rates (IRR = 0.69, 95%CI = 0.61-0.79), with higher relative presentation of large vessel occlusion (risk ratio (RR) = 1.62, 95% confidence interval (CI) = 1.24-2.12). Proportions of patients treated with endovascular treatment increased (RR = 1.14, 95%CI = 1.02-1.28). Intravenous thrombolysis decreased overall (IRR = 0.72, 95%CI = 0.54-0.96) but not in the mothership model (IRR = 0.81, 95%CI = 0.43-1.52). Onset-to-door time was longer for the drip&ship in COVID-period compared to the control-period (+32 min, 95%CI = 0-64). Door-to-scan was longer in COVID-period (+5 min, 95%CI = 2-7). Door-to-needle and door-to-groin were similar in COVID-period and control-period. CONCLUSIONS Despite a 35% drop in stroke admissions during the first pandemic wave, proportions of patients receiving reperfusion and time-metrics were not inferior to control-period. Mothership preserved the weekly rate of intravenous thrombolysis and the onset-to-door timing to pre-pandemic standards.
Collapse
Affiliation(s)
- Michele Romoli
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, “C.A. Pizzardi” Maggiore Hospital, Bologna, Italy
- Neurology and Stroke Unit, Department of Neuroscience, “Maurizio Bufalini” Hospital, Cesena, Italy
- Neurology Clinic, University of Perugia – S. Maria della Misericordia Hospital, Perugia, Italy
| | - Paolo Eusebi
- Public Health Authority, Regione Umbria, Perugia, Italy
| | - Stefano Forlivesi
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, “C.A. Pizzardi” Maggiore Hospital, Bologna, Italy
| | - Mauro Gentile
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, “C.A. Pizzardi” Maggiore Hospital, Bologna, Italy
| | - Fabrizio Giammello
- International PhD in Translational Molecular Medicine and Surgery, Department of BIOMORF – University of Messina, Messina, Italy
| | - Laura Piccolo
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, “C.A. Pizzardi” Maggiore Hospital, Bologna, Italy
| | - David Giannandrea
- Neurologia e Stroke Unit, Ospedale di Gubbio e Gualdo Tadino, Perugia, Italy
| | - Simone Vidale
- Neurology Unit, Rimini “Infermi” Hospital, AUSL Romagna, Rimini, Italy
| | - Marco Longoni
- Neurology and Stroke Unit, Department of Neuroscience, “Maurizio Bufalini” Hospital, Cesena, Italy
| | - Matteo Paolucci
- Neurology and Stroke Unit, Department of Neuroscience, “Maurizio Bufalini” Hospital, Cesena, Italy
| | - Jessica Hsiao
- Department of Neurology, University of Cincinnati, USA
| | - Emily Sayles
- Department of Neurology, University of Cincinnati, USA
| | - Leonard LL Yeo
- Division of Neurology, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Espen Saxhaug Kristoffersen
- Department of Neurology, Akershus University Hospital, Lørenskog, Norway
- Department of General Practice, HELSAM, University of Oslo, Oslo, Norway
| | - Angel Chamorro
- Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic, University of Barcelona, Barcelona, Spain
- “August Pi i Sunyer” Biomedical Research Institute (IDIBAPS), Barcelona, Spain
| | - Liqun Jiao
- Department of Neurosurgery, Xuanwu Hospital, Beijing, China
| | - Pooja Khatri
- Department of Neurology, University of Cincinnati, USA
| | - Georgios Tsivgoulis
- Department of Neurology, University of Tennessee Health Science Center, Memphis, USA
- Second Department of Neurology, “Attikon” University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
| | - Maurizio Paciaroni
- Neurology – Stroke Unit, Ospedale San Giuseppe, IRCCS MultiMedica, Milano, Italy
| | - Andrea Zini
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Neurology and Metropolitan Stroke Center, “C.A. Pizzardi” Maggiore Hospital, Bologna, Italy
| |
Collapse
|
42
|
Han HJ, Park KY, Kim J, Lee W, Lee YH, Jang CK, Cho KC, Park SK, Chung J, Kwon YS, Kim YB, Lee JW, Kim SY. Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era. Yonsei Med J 2021; 62:911-917. [PMID: 34558870 PMCID: PMC8470569 DOI: 10.3349/ymj.2021.62.10.911] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 06/25/2021] [Accepted: 06/25/2021] [Indexed: 12/23/2022] Open
Abstract
PURPOSE The coronavirus disease 2019 (COVID-19) pandemic disrupted the emergency medical care system worldwide. We analyzed the changes in the management of intracerebral hemorrhage (ICH) and compared the pre-COVID-19 and COVID-19 eras. MATERIALS AND METHODS From March to October of the COVID-19 era (2020), 83 consecutive patients with ICH were admitted to four comprehensive stroke centers. We retrospectively reviewed the data of patients and compared the treatment workflow metrics, treatment modalities, and clinical outcomes with the patients admitted during the same period of pre-COVID-19 era (2017-2019). RESULTS Three hundred thirty-eight patients (83 in COVID-19 era and 255 in pre-COVID-19 era) were included in this study. Symptom onset/detection-to-door time [COVID-19; 56.0 min (34.0-106.0), pre-COVID-19; 40.0 min (27.0-98.0), p=0.016] and median door to-intensive treatment time differed between the two groups [COVID-19; 349.0 min (177.0-560.0), pre-COVID-19; 184.0 min (134.0-271.0), p<0.001]. Hematoma expansion was detected more significantly in the COVID-19 era (39.8% vs. 22.1%, p=0.002). At 3-month follow-up, clinical outcomes of patients were worse in the COVID-19 era (Good modified Rankin Scale; 33.7% in COVID19, 46.7% in pre-COVID-19, p=0.039). CONCLUSION During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes.
Collapse
Affiliation(s)
- Hyun Jin Han
- Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Keun Young Park
- Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Junhyung Kim
- Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Woosung Lee
- Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Yun Ho Lee
- Department of Neurosurgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea
| | - Chang Ki Jang
- Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
| | - Kwang-Chun Cho
- Department of Neurosurgery, International St. Mary's Hospital, Catholic Kwandong University, Inchoen, Korea
| | - Sang Kyu Park
- Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Joonho Chung
- Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Young Sub Kwon
- Department of Neurosurgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea
| | - Yong Bae Kim
- Department of Neurosurgery, Severance Stroke Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | - Jae Whan Lee
- Department of Neurosurgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
| | - So Yeon Kim
- Department of Neurosurgery, International St. Mary's Hospital, Catholic Kwandong University, Inchoen, Korea.
| |
Collapse
|
43
|
Frank TS, Lee JE, Starke RM, Mokin M, Colby GP, Wang AC, Johnson J, Burkhardt JK, Srinivasan V, Raper DM, Albuquerque F, Kan P. Endovascular cerebral aneurysm treatment volume during coronavirus 2019. Interv Neuroradiol 2021; 28:391-395. [PMID: 34515557 PMCID: PMC9326863 DOI: 10.1177/15910199211040278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Affiliation(s)
- Thomas S Frank
- Department of Neurosurgery, 12338University of Texas Medical Branch, USA
| | - Jae E Lee
- Department of Neurosurgery, 3989Baylor College of Medicine, USA
| | | | - Maxim Mokin
- Department of Neurosurgery, 466214University of South Florida, USA
| | - Geoffrey P Colby
- Department of Neurosurgery, 189530University of California Los Angeles, USA
| | - Anthony C Wang
- Department of Neurosurgery, 189530University of California Los Angeles, USA
| | | | | | | | - Daniel Ms Raper
- Department of Neurosurgery, 3989Baylor College of Medicine, USA
| | | | - Peter Kan
- Department of Neurosurgery, 12338University of Texas Medical Branch, USA
| |
Collapse
|
44
|
Pfaff JAR, Harlan ME, Pfaff G, Hubert A, Bendszus M. Neuroradiological emergency consultations during the first year of the COVID-19 pandemic. Neurol Res Pract 2021; 3:47. [PMID: 34455980 PMCID: PMC8403519 DOI: 10.1186/s42466-021-00147-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 07/28/2021] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND Measures taking aim at minimizing the risk of coronavirus transmission and fear of infection may affect decisions to seek care for other medical emergency conditions. The purpose of this analysis was to analyze intermediate-term effects of the COVID-19 pandemic on neuroradiological emergency consultations (NECs). METHODS We conducted an ambispective study on NEC requests to a university hospital from a teleradiological network covering 13 hospitals in Germany. Weekly NEC rates for prepandemic calendar weeks (CW) 01/2019-09/2020 were compared with rates during first COVID-19 wave (CW 10-20/2020), first loosening of restrictions (CW 21-29/2020), intensified COVID-19 testing (CW 30-39/2020) and second COVID-19 wave (CW 40-53/2020), and contrasted with COVID-19 incidence in Germany. RESULTS A total of n = 10 810 NECs were analyzed. Prepandemic NEC rates were stable over time (median: 103, IQR: 97-115). Upon the first COVID-19 wave in Germany, NEC rates declined sharply (median: 86, IQR: 69-92; p < 0.001) but recovered within weeks. Changes in NEC rates after first loosening of restrictions (median: 109, IQR: 98-127; p = 0. 188), a phase of intensified testing (median: 111, IQR: 101-114; p = 0.434) and as of a second COVID-19 wave (median: 102, IQR: 94-112; p = 0. 462) were not significant. Likewise, patient age and gender distribution remained constant. CONCLUSION Upon the first pandemic COVID-19 wave in Germany, NEC rates declined but recovered within weeks. It is unknown whether this recovery reflects improved medical care and test capabilities or an adjustment of the patients' behaviour.
Collapse
Affiliation(s)
- Johannes A. R. Pfaff
- Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
- University Institute for Neuroradiology of the Paracelsus Medical University, Uniklinikum Salzburg, Christian-Doppler-Klinik, Ignaz-Harrer-Straße 79, A-5020 Salzburg, Austria
| | - Marcial E. Harlan
- Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Günter Pfaff
- Visiting Lecturer in Epidemiology and Psychiatric Epidemiology, Protestant University of Applied Sciences Ludwigsburg, Paulusweg 6, 71638 Ludwigsburg, Germany
| | - Alexander Hubert
- Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| | - Martin Bendszus
- Department of Neuroradiology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
| |
Collapse
|
45
|
Böjti PP, Szilágyi G, Dobi B, Stang R, Szikora I, Kis B, Kornfeld Á, Óváry C, Erőss L, Banczerowski P, Kuczyński W, Bereczki D. Impact of COVID-19 on ischemic stroke care in Hungary. GeroScience 2021; 43:2231-2248. [PMID: 34406562 PMCID: PMC8371604 DOI: 10.1007/s11357-021-00424-z] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2021] [Accepted: 07/20/2021] [Indexed: 11/29/2022] Open
Abstract
Data about the coronavirus disease 2019 (COVID-19) pandemic’s collateral damage on ischemic stroke (IS) care during the second epidemic wave in Central Europe are limited. We sought to evaluate the impact of the COVID-19 outbreak on Hungarian IS care during the two epidemic waves. This retrospective observational study was based on a nationwide reimbursement database that encompasses all IS admissions and all reperfusion interventions, i.e., intravenous thrombolysis (IVT) and endovascular therapy (EVT) from 2 January 2017 to 31 December 2020 in Hungary. COVID-19 pandemic’s effect on the number of IS admissions and reperfusion interventions were analyzed using different statistics: means, medians, trends, relative rates, and linear relationships. The mean and median values of IS admissions and reperfusion interventions decreased only in some measure during the COVID-periods. However, trend analysis demonstrated a significant decline from the trends. The decline’s dynamic and amplitude have differed for each variable. In contrast to IVT, the number of IS admissions and EVTs negatively correlated with the epidemic waves’ amplitude. Besides, the decrease in the number of IS admissions was more pronounced than the decrease in the number of reperfusion interventions. Our study demonstrated a significant disruption in IS care during the COVID-19 epidemic in Hungary, in which multiple different factors might play a role. The disproportionate reduction of IS admission numbers could partially be explained by the effect of health emergency operative measures and changes in patients’ social behavior. Further studies are needed to evaluate the causes of our observations.
Collapse
Affiliation(s)
- Péter Pál Böjti
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary. .,National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.
| | - Géza Szilágyi
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,Department of Neurology, Medical Centre, Hungarian Defence Forces, Budapest, Hungary
| | - Balázs Dobi
- Department of Probability Theory and Statistics, Eötvös Loránd University, Budapest, Hungary.,Neuroepidemiology Research Group ELKH, MTA-SE, Budapest, Hungary
| | - Rita Stang
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,Department of Probability Theory and Statistics, Eötvös Loránd University, Budapest, Hungary
| | - István Szikora
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.,Department of Neurosurgery, Semmelweis University, Budapest, Hungary
| | - Balázs Kis
- National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary
| | - Ákos Kornfeld
- National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary
| | - Csaba Óváry
- National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary
| | - Lóránd Erőss
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.,Department of Neurosurgery, Semmelweis University, Budapest, Hungary
| | - Péter Banczerowski
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,National Institute of Mental Health, Neurology and Neurosurgery, Budapest, Hungary.,Department of Neurosurgery, Semmelweis University, Budapest, Hungary
| | - Wojciech Kuczyński
- Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Lodz, Poland
| | - Dániel Bereczki
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Balassa utca 6., Budapest, 1083, Hungary.,Neuroepidemiology Research Group ELKH, MTA-SE, Budapest, Hungary.,Department of Neurology, Semmelweis University, Budapest, Hungary.,European Academy of Neurology, EANcore COVID-19 Task Force, Vienna, Austria
| |
Collapse
|
46
|
Choi A, Kim HY, Cho A, Noh J, Park I, Chung HS. Efficacy of a four-tier infection response system in the emergency department during the coronavirus disease-2019 outbreak. PLoS One 2021; 16:e0256116. [PMID: 34383840 PMCID: PMC8360518 DOI: 10.1371/journal.pone.0256116] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Accepted: 07/31/2021] [Indexed: 12/23/2022] Open
Abstract
Introduction The coronavirus disease (COVID-19) pandemic has delayed the management of other serious medical conditions. This study presents an efficient method to prevent the degradation of the quality of diagnosis and treatment of other critical diseases during the pandemic. Methods We performed a retrospective observational study. The primary outcome was ED length of stay (ED LOS). The secondary outcomes were the door-to-balloon time in patients with suspected ST-segment elevation myocardial infarction and door-to-brain computed tomography time for patients with suspected stroke. The outcome measures were compared between patients who were treated in the red and orange zones designated as the changeable isolation unit and those who were treated in the non-isolation care unit. To control confounding factors, we performed propensity score matching, following which, outcomes were analyzed for non-inferiority. Results The mean ED LOS for hospitalized patients in the isolation and non-isolation care units were 406.5 min (standard deviation [SD], 237.9) and 360.2 min (SD, 226.4), respectively. The mean difference between the groups indicated non-inferiority of the isolation care unit (p = 0.037) but not in the patients discharged from the ED (p>0.999). The mean difference in the ED LOS for patients admitted to the ICU between the isolation and non-isolation care units was -22.0 min (p = 0.009). The mean difference in the door-to-brain computed tomography time between patients with suspected stroke in the isolation and non-isolation care units was 7.4 min for those with confirmed stroke (p = 0.013), and -20.1 min for those who were discharged (p = 0.012). The mean difference in the door-to-balloon time between patients who underwent coronary angiography in the isolation and non-isolation care units was -2.1 min (p<0.001). Conclusions Appropriate and efficient handling of a properly planned ED plays a key role in improving the quality of medical care for other critical diseases during the COVID-19 outbreak.
Collapse
Affiliation(s)
- Arom Choi
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Ha Yan Kim
- Department of Biomedical Systems Informatics, Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea
| | - Ara Cho
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Jiyoung Noh
- Center for Disaster Relief, Training, and Research, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
| | - Incheol Park
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Hyun Soo Chung
- Department of Emergency Medicine, Yonsei University College of Medicine, Seoul, South Korea
- Center for Disaster Relief, Training, and Research, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
- * E-mail:
| |
Collapse
|
47
|
Sedova P, Brown Jr. RD, Bryndziar T, Jarkovsky J, Tomek A, Sramek M, Skoda O, Sramkova T, Littnerova S, Mikulik R. Treat COVID-19, but Not Only COVID-19: Stroke Matters as Well. Cerebrovasc Dis 2021; 51:52-59. [PMID: 34515067 PMCID: PMC8450853 DOI: 10.1159/000517968] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Accepted: 06/16/2021] [Indexed: 12/24/2022] Open
Abstract
INTRODUCTION During the COVID-19 pandemic, studies reported less number of hospitalizations for acute stroke and reduction in the use of recanalization treatments. This study analyzes nationwide data on stroke admissions and management in the Czech Republic during the first wave of the COVID-19 pandemic. METHODS We compared the early COVID-19 pandemic (March-May 2020) with the pre-pandemic period (January-February 2020 and March-May 2019): (a) the National Register of Reimbursed Health Services provided volume of all admissions for subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS), and volume of recanalization treatments (intravenous thrombolysis [IVT] and mechanical thrombectomy [MT]); (b) Registry of Stroke Care Quality provided door-to-needle time (DNT), onset-to-door time (ODT), and stroke severity at admission (National Institutes of Health Stroke Scale, NIHSS) for IS. RESULTS During the pandemic (March-May 2020), the peak number of COVID-19 patients treated in Czech hospitals was 39 per million. In March-May 2020 versus March-May 2019, hospital admissions decreased as follows: stroke overall by 14% (p < 0.001), IS by 14% (p < 0.001), SAH by 15% (p = 0.07), and ICH by 7% (p = 0.17). The mean age was 74 years versus 74 years (p = 0.33), and 52% versus 51% were men (p = 0.34). The volumes of IVT and MT decreased by 14% (p = 0.001) and 19% (p = 0.01), respectively. The proportions of all IS patients receiving IVT or MT remained unchanged, with, respectively, 17% versus 17% receiving IVT (p = 0.86) and 5% versus 5% receiving MT (p = 0.48). DNT and ODT were 24 versus 25 min (p = 0.58) and 168 versus 156 min (p = 0.23), respectively. NIHSS at admission did not differ (6 vs. 6; p = 0.54). CONCLUSION Even with a low burden of COVID-19 during the first wave and no change in organization and logistics of stroke services, stroke admissions and volume of recanalization treatments decreased. Public health communication campaigns should encourage people to seek emergency medical care for stroke symptoms during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Petra Sedova
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA
- International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czechia
- Department of Neurology, St. Anne's University Hospital, Brno, Czechia
- Faculty of Medicine, Masaryk University, Brno, Czechia
| | | | - Tomas Bryndziar
- International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia
- Department of Neurology, St. Anne's University Hospital, Brno, Czechia
- Faculty of Medicine, Masaryk University, Brno, Czechia
| | - Jiri Jarkovsky
- Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia
- Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
| | - Ales Tomek
- Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czechia
| | - Martin Sramek
- Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czechia
| | - Ondrej Skoda
- Neurological Department and Stroke Unit, Jihlava Hospital, Jihlava, Czechia
- Department of Neurology, University Hospital Kralovske Vinohrady and Charles University in Prague, Prague, Czechia
| | - Tereza Sramkova
- Department of Neurology, Charles University in Prague, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czechia
| | - Simona Littnerova
- Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia
- Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
| | - Robert Mikulik
- International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia
- Department of Neurology, St. Anne's University Hospital, Brno, Czechia
- Faculty of Medicine, Masaryk University, Brno, Czechia
| |
Collapse
|
48
|
Peng G, Nie X, Liebeskind D, Liu L, Miao Z. Management of endovascular therapy for acute ischemic stroke amid the COVID-2019 pandemic: a multicenter survey in China. Neurol Res 2021; 43:823-830. [PMID: 34375569 DOI: 10.1080/01616412.2021.1939236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Objectives: The impact of COVID-19 pandemic on endovascular therapy (EVT) for acute ischemic stroke in China is unknown. This study was aimed to verify the volume change of EVT for acute ischemic stroke affected by COVID-19 and its potential factors.Methods: This cross-sectional study was conducted via an online questionnaire survey in China. The questionnaire was mainly composed of descriptive information, volume change of EVT for acute ischemic stroke, and the protection status of medical staff.Results: A total of 103 stroke physicians in 28 provinces across China completed the survey questionnaire. A volume decline in EVT for acute stroke occurred in 93 (90.3%) hospitals after lockdown (23 January 2020). Nearly half of the hospitals (51/103, 49.5%) experienced a volume decline of EVT case more than 50% and 14 (13.6%) hospitals completely ceased offering EVT. Hospitals with decline >50% of EVT case had higher proportion of hospitals with a designated area for COVID-19 screening in the emergency room (44/51, 86.3% vs 34/52, 65.4%, p= 0.01) and medical staff in quarantine (19/51, 37.3% vs 7/52, 13.5%, p< 0.01), with lower proportion of hospitals with personal protective equipment protocol (41/51, 80.4% vs 49/52, 94.2%, p= 0.03) than hospitals with decline ≤50%.Conclusions: The volume of EVT for acute ischemic stroke severely declined after lockdown in China. Designating a specific area for COVID-19 screening, insufficient personal protection and understaffing may exacerbate the volume decline of EVT.
Collapse
Affiliation(s)
- Guangge Peng
- Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China
| | - Ximing Nie
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - David Liebeskind
- Department of Neurology, Neurovascular Imaging Research Core and UCLA Stroke Center, University of California, Los Angeles, CA, USA
| | - Liping Liu
- China National Clinical Research Center for Neurological Diseases, Beijing, China.,Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
| | - Zhongrong Miao
- Interventional Neuroradiology Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.,China National Clinical Research Center for Neurological Diseases, Beijing, China
| |
Collapse
|
49
|
Katsanos AH, Palaiodimou L, Zand R, Yaghi S, Kamel H, Navi BB, Turc G, Benetou V, Sharma VK, Mavridis D, Shahjouei S, Catanese L, Shoamanesh A, Vadikolias K, Tsioufis K, Lagiou P, Sfikakis PP, Alexandrov AV, Tsiodras S, Tsivgoulis G. Changes in Stroke Hospital Care During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Stroke 2021; 52:3651-3660. [PMID: 34344166 PMCID: PMC8547579 DOI: 10.1161/strokeaha.121.034601] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
BACKGROUND AND PURPOSE We systematically evaluated the impact of the coronavirus 2019 (COVID-19) pandemic on stroke care across the world. METHODS Observational studies comparing characteristics, acute treatment delivery, or hospitalization outcomes between patients with stroke admitted during the COVID-19 pandemic and those admitted before the pandemic were identified by Medline, Scopus, and Embase databases search. Random-effects meta-analyses were conducted for all outcomes. RESULTS We identified 46 studies including 129 491 patients. Patients admitted with stroke during the COVID-19 pandemic were found to be younger (mean difference, -1.19 [95% CI, -2.05 to -0.32]; I2=70%) and more frequently male (odds ratio, 1.11 [95% CI, 1.01-1.22]; I2=54%) compared with patients admitted with stroke in the prepandemic era. Patients admitted with stroke during the COVID-19 pandemic, also, had higher baseline National Institutes of Health Stroke Scale scores (mean difference, 0.55 [95% CI, 0.12-0.98]; I2=90%), higher probability for large vessel occlusion presence (odds ratio, 1.63 [95% CI, 1.07-2.48]; I2=49%) and higher risk for in-hospital mortality (odds ratio, 1.26 [95% CI, 1.05-1.52]; I2=55%). Patients with acute ischemic stroke admitted during the COVID-19 pandemic had higher probability of receiving endovascular thrombectomy treatment (odds ratio, 1.24 [95% CI, 1.05-1.47]; I2=40%). No difference in the rates of intravenous thrombolysis administration or difference in time metrics regarding onset to treatment time for intravenous thrombolysis and onset to groin puncture time for endovascular thrombectomy were detected. CONCLUSIONS The present systematic review and meta-analysis indicates an increased prevalence of younger patients, more severe strokes attributed to large vessel occlusion, and higher endovascular treatment rates during the COVID-19 pandemic. Patients admitted with stroke during the COVID-19 pandemic had higher in-hospital mortality. These findings need to be interpreted with caution in view of discrepant reports and heterogeneity being present across studies.
Collapse
Affiliation(s)
- Aristeidis H Katsanos
- Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, Canada (A.H.K., L.C., A.S.).,Second Department of Neurology, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece (A.H.K., L.P., G. Tsivgoulis.)
| | - Lina Palaiodimou
- Second Department of Neurology, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece (A.H.K., L.P., G. Tsivgoulis.)
| | - Ramin Zand
- Neurosience Institute, Geisinger Health System, Danville, Pennsylvania (R.Z., S.S.)
| | - Shadi Yaghi
- Department of Neurology, NYU Langone Health, NY (S.Y.)
| | - Hooman Kamel
- Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, NY (H.K., B.B.N.)
| | - Babak B Navi
- Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, NY (H.K., B.B.N.)
| | - Guillaume Turc
- Department of Neurology, GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, France (G. Turc).,Université de Paris, France (G. Turc).,INSERM U1266, Paris, France (G. Turc).,FHU Neurovasc, Paris, France (G. Turc)
| | - Vassiliki Benetou
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece (V.B., P.L.)
| | - Vijay K Sharma
- Division of Neurology, Department of Medicine, National University Hospital, Singapore and School of Medicine, National University of Singapore (V.K.S.)
| | - Dimitris Mavridis
- Department of Primary Education, University of Ioannina, Greece (D.M.).,Université Paris Descartes, Faculté de Médecine, France (D.M.)
| | - Shima Shahjouei
- Neurosience Institute, Geisinger Health System, Danville, Pennsylvania (R.Z., S.S.)
| | - Luciana Catanese
- Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, Canada (A.H.K., L.C., A.S.)
| | - Ashkan Shoamanesh
- Division of Neurology, McMaster University/Population Health Research Institute, Hamilton, Canada (A.H.K., L.C., A.S.)
| | - Konstantinos Vadikolias
- Department of Neurology, School of Medicine, Democritus University of Thrace, Alexandroupolis, Greece (K.V.)
| | - Konstantinos Tsioufis
- First Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Greece (K.T.)
| | - Pagona Lagiou
- Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Greece (V.B., P.L.).,Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA (P.L.)
| | - Petros P Sfikakis
- Joint Rheumatology Program, First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Greece (P.P.S.)
| | - Andrei V Alexandrov
- Department of Neurology, University of Tennessee Health Science Center, Memphis (A.V.A., G. Tsivgoulis)
| | - Sotirios Tsiodras
- Fourth Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Greece (S.T.).,National Public Health Organization of Greece, Athens (S.T.)
| | - Georgios Tsivgoulis
- Second Department of Neurology, "Attikon" Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece (A.H.K., L.P., G. Tsivgoulis.).,Department of Neurology, University of Tennessee Health Science Center, Memphis (A.V.A., G. Tsivgoulis)
| |
Collapse
|
50
|
Sobolewski P, Szczuchniak W, Grzesiak-Witek D, Wilczyński J, Paciura K, Antecki M, Frańczak-Prochowski T, Kos M, Kozera G. Stroke Care During the First and the Second Waves of the COVID-19 Pandemic in a Community Hospital. Front Neurol 2021; 12:655434. [PMID: 34408718 PMCID: PMC8365035 DOI: 10.3389/fneur.2021.655434] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2021] [Accepted: 06/07/2021] [Indexed: 01/08/2023] Open
Abstract
Objective: The coronavirus disease 2019 (COVID-19) infection may alter a stroke course; thus, we compared stroke course during subsequent pandemic waves in a stroke unit (SU) from a hospital located in a rural area. Methods: A retrospective study included all patients consecutively admitted to the SU between March 15 and May 31, 2020 ("first wave"), and between September 15 and November 30, 2020 ("second wave"). We compared demographic and clinical data, treatments, and outcomes of patients between the first and the second waves of the pandemic and between subjects with and without COVID-19. Results: During the "first wave," 1.4% of 71 patients were hospitalized due to stroke/TIA, and 41.8% of 91 during the "second wave" were infected with SARS-CoV-2 (p < 0.001). During the "second wave," more SU staff members were infected with COVID-19 than during the "first wave" (45.6 vs. 8.7%, p < 0.001). Nevertheless, more patients underwent intravenous thrombolysis (26.4 vs. 9.9%, p < 0.008) and endovascular thrombectomy (5.3 vs. 0.0%, p < 0.001) during the second than the first wave. Large vessel occlusion (LVO) (OR 8.74; 95% CI 1.60-47.82; p = 0.012) and higher 30-day mortality (OR 6.01; 95% CI 1.04-34.78; p = 0.045) were associated with patients infected with COVID-19. No differences regarding proportions between ischemic and hemorrhagic strokes and TIAs between both waves or subgroups with and without COVID-19 existed. Conclusion: Despite the greater COVID-19 infection rate among both SU patients and staff during the "second wave" of the pandemic, a higher percentage of reperfusion procedures has been performed then. COVID-19 infection was associated with a higher rate of the LVO and 30-day mortality.
Collapse
Affiliation(s)
- Piotr Sobolewski
- Department of Neurology and Stroke Unit in Sandomierz, Jan Kochanowski University, Kielce, Poland
- Collegium Medicum, Jan Kochanowski University, Kielce, Poland
| | - Wiktor Szczuchniak
- Department of Neurology and Stroke Unit in Sandomierz, Jan Kochanowski University, Kielce, Poland
| | - Danuta Grzesiak-Witek
- Department of Neurology and Stroke Unit in Sandomierz, Jan Kochanowski University, Kielce, Poland
- Institute of Literature and Linguistics, Jan Kochanowski University, Kielce, Poland
| | | | - Karol Paciura
- Department of Neurology and Stroke Unit in Sandomierz, Jan Kochanowski University, Kielce, Poland
| | - Mateusz Antecki
- Department of Neurology and Stroke Unit in Sandomierz, Jan Kochanowski University, Kielce, Poland
| | | | - Marek Kos
- Department of Public Health, Medical University of Lublin, Lublin, Poland
| | - Grzegorz Kozera
- Medical Simulation Center, Medical University of Gdańsk, Gdańsk, Poland
| |
Collapse
|